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N-(DEOXYADENOSINE-8-YL)-4-AMINOBIPHENYL ADDUCT FORMATION
IN VITRO ON TP53 EXON7 GENOME: QUANTITATION BY LC-ESI-MS/MS
Paul Rene Knoll, M.S.
Western Michigan University, 2008
The p53 protein has been documented to be mutated in more than 50 % of late
stage bladder cancers and tobacco causes 50 % of all bladder tumors. The 4arninobiphenyl (ABP) carcinogen comprises 5 ng per cigarette in the smoke and is a
known bladder carcinogen. The research goal in the present study was to compare the
reactivity of rat liver S-9 fraction activated 4-arninobiphenyl with the 45-mer sense strand
of the TP53 exon7 gene to the respective anti-sense strand. The specific and sensitive
technique of LC-tandem mass spectrometry (LC-MS/MS) was used for quantitation. The
authentic standard of N-(adenine-8yl-)-4-arninobiphenyl (A-ABP) adduct was prepared
by Buchwald-Hartwig coupling, used for MS tuning and LC-MS/MS calibration. The
LC-MS/MS (n = 4, p = 0.10) results were 6 ± 3 and 10 ± 6 fmol on the column or
reaction results of 5 ± 2 and 9 ± 4 N-(deoxyadenosine-8-yl)-4-aminobiphenyl (dA-ABP)
adducts / 106 nucleotides in the oligo for the sense and anti-sense strands, respectively.
There were 8 vs. 5 dA and 9 vs. 4 dG non-hydrogen-bonded purines available for the
sense and anti-sense strands, respectively, in the computationally folded oligos. Tne
decreased reactivity measured for the sense strand is corroborated by computationally
derived ssDNA secondary structure results that suggest that the sense strand ratio of
available reactive dA to dG loci is less when compared to the anti-sense strand.
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CHAPTER I
INTRODUCTION
Tobacco smoking is involved in 90% of the cases of lung cancer which is roughly
30% of the cancer cases in developed countries. Smoking is involved in other human
cancers including: oral cavity, naso-, oro-, and hypopharynx, nasal cavity and paranasal
sinuses, larynx, esophagus, stomach, pancreas, liver, kidney, ureter, urinary bladder,
uterine cervix, and bone marrow (myeloid leukemia). 1 500 million of those alive today
will die due to tobacco use.2 There are 81 International Agency for Research on Cancer
(IARC) classified carcinogens in cigarette "mainstream" smoke,3 the smoke that is
directly inhaled by the smoker. The organic compounds classified as IARC Group 1
carcinogens, i.e., known human carcinogens are: 4-aminobiphenyl, benzene, 2napthylamine, vinyl chloride and ethylene oxide.3 Historically occupational sources of
urinary bladder cancer have included 2-napthylamine and benzidine used in the dye
industry. The use of these compounds has been banned since 1950 and 1962,
respectively. The 4-aminobiphenyl (ABP) non-protected commercial production was
stopped in 1949 when increased bladder cancer was observed in workers.4 The ABP
carcinogen comprises 5 ng per cigarette in the smoke. 5 ABP may also be present in some
permanent hair dyes due to batch to batch variations in the synthesis of the main colorant
1,4-phenylenediamine.6 ABP has been shown to be a human bladder carcinogen and is
now regulated. 7• 8

2
Tobacco causes 50% of all bladder tumors.9 ABP forms carcinogen-DNA
adducts in urothelial cells.1° Compared to those who have never smoked, ex-smokers are
1.9 times as likely to have bladder cancer, and current smokers 3.3 times as likely.1 1 In
an epidemiological review Silverman et.al. summarized that smokers have two to three
times the risk compared to non-smokers of developing bladder cancer and that avoiding
cigarette smoking was the best way to prevent bladder cancer.4
The "somatic mutation hypothesis" for cancer holds that cancer forms because of
mutations on specific genes called "oncogenes and tumor suppressor genes."12 The TP53
tumor suppressor gene has mutations in 5 to 80 % of all types of human cancers.13 The
p53 protein has mutations in 30 % of bladder cancers overall 1 4 and has been documented
to be mutated in more than 50% of late stage bladder cancers.13 ABP is 50 times as
mutagenic in single stranded DNA (ssDNA) compared to double stranded DNA
(dsDNA). 15 The N-(deoxyguanosin-8-yl)-ABP (dGuo-8yl-ABP) adduct and a few other
adducts were found to be the result of smoking.10 The objective of this research project
was to quantitate one of those other adducts, N-(deoxyadenosin-8yl)-ABP (dAdo-8yl
ABP) 15-20 and to explore the relative potential of the adenine residues in each ssDNA
strand to form ABP-adducts. The ssDNA substrates used for the in vitro analyses were
the coding (sense) and the transcriptional (anti-sense) strands of the synthetic 45
nucleotide long (45-mer) TP53 exon 7 gene.
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CHAPTER II
LITERATURE REVIEW
Function of p53 Tumor Suppressor Protein and Bladder Cancer
Overview
The p53 protein causes cell cycle arrest or apoptosis.21-23 It functions by
inhibiting the cycle of abnormal, or stressed cells allowing damaged DNA to be repaired
or by stopping growth permanently. Apoptosis, meaning programmed cell death,
happens when the abnormality / stress continues or occurs when the cell is in replication.
Another function of the p53 protein may be to inhibit angiogenesis and metastasis.22
Stress signals upstream to the p53 protein include: DNA damage, hypoxia, ribonucleotide
triphosphate depletion, telomere damage, nitric oxide (NO), and oncogene activation.21• 22
The p53 protein has been called the "guardian of the genome" because of these
functions.21' 24
Domains of p53
The 393 amino acid residue p53 protein binds to DNA as a dimer of dimers, or a
tetramer and is constitutively expressed in almost all cell types.13 The p53 protein either
activates or represses transcription of a large number of genes. 23 In the un-stressed cell
the p53 levels remain relatively low due to rapid tumover.23• 25 There is a constant
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degradation of the p53 protein giving it a very short half-life.21 The N-terminus of the
p53 protein where it interacts with target genes is blocked by the nuclear protein MDM2,
the central regulator of p53.25 MDM2 functions as an E3 ubiquitin ligase marking p53
for monoubiquitination thus promoting p53 nuclear export and proteomic destruction in
the cytosol.23• 25 But MDM2 is itself a transcriptional target of p53 making an
autoregulatory feedback loop between the two.
The p53 protein initiates growth arrest and/ or apoptosis through upregulation of
p53-mediated transcription functions. Post-translational modifications are the mediator
of these changes. Modifications include phosphorylation by kinases on the N-terminus to
regulate p53 stability and on the C-terminal Ser 392 to activate DNA binding and
transcriptional function. Acetylation at C-terminal Lys 382 activates DNA binding and
sumoylation at one of the p53 Lys residues enhances transcription.21 The C-terminus
maintains the p53 protein in its latent form by physical interactions with parts of the N
terminus and/ or the DNA binding domain.13
The DNA binding domain of p53 binds to DNA consensus sequences of two
copies of RRRCWWGYYY in which R is a purine, W is either A or T and Y is a
pyrimidine both separated by a 0-21 base pair spacer. There are 30-35 of these response
sequences in the human genome.22 The main p53 contact in the minor groove with DNA
is via Arg 248 and in the major groove to DNA are via Lys 120, Ser 241, Arg 273, Ala
276, Cys 277 and Arg 283. A zinc atom is held by Cys 176, His 179, Cys 238 and Cys
242 through chelation preventing the DNA binding domain from unfolding. 13 3-0
modeling studies indicated that p53 bends the DNA toward the major groove at the
pentamer junction allowing optimal binding in the minor groove. 13
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The DNA binding domain is flanked by the proline-rich domain on its N-terminus
and the oligomerization domain on its C-terminus. The proline-rich domain is necessary
for p53 regulated apoptosis but not growth arrest. The oligomerization domain is where
the four monomers associate to form the tetramer. 13
Mutations
The DNA binding domain of TP53, exons 5 through 8, contains 90 % of the
known p53 mutations in human cancer and 83 % of these are single nucleotide missense
mutations. 14 The two arginine codons 248 and 273 mentioned above are in direct contact
with the DNA. Arginines 175, 249 and 282 provide stability to the DNA binding
surface. 13• 26 Including glycine at codon 245, these account for 28 % of the missense
mutations in TP53. 14 They are called hot spots. Mutated p53 fails to bind to the DNA
response elements efficiently.22 Genetically inherited TP53 mutations are associated with
the rare Li-Fraumeni Syndrome which has the diagnostic criteria of early onset of cancer
with both first, and another first- or second-degree relative with < 45 year old onset of
cancer.27
There are two types of base substitution mutational events that can take place in
DNA: transversions and transitions. Transversions occur when a purine converts to the
other purine or a pyrimidine to the pyrimidine (G� ➔ A or C� ➔ T). Transitions are
when purine converts to pyrimidine or vice versa. (G� ➔ C, G� ➔ T, A� ➔ C or
A� ➔ T). In the nucleotide sequence CpG, the cytosine is often methylated at the C-5
position. Without methylation the frequent deamination of cytosine produces uracil
which can be repaired routinely by uracil glycosylases. But when cytosine is methylated
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the 5-methyl cytosine (5mC) becomes thymine,un-repairable by the enzymes. This
accounts for a 10 to 50 fold increase for the C ➔ T transition over the other three
transitions. 14
Table 1 is a curated list of the IARC database hot spot mutations in bladder cancer
as of March 2007.
Table 1. Human Bladder Cancer Hotspots
Hotspots on exon7 in Italics
Source: T Soussi,J.M. Rubio-Nevada,D. Hamroun and C. Beroud.
The p53 Mutation handbook,available online; http://p53.free.fr

Codon
285
280
248
175
273
280
248
220
271
245

Codon
Mutation
GAG ➔ AAG
AGA ➔ ACA
CGG ➔ CAG
coc➔ cAc
COT ➔ CAT
AGA ➔ AAA
CGG ➔ TGG
TAT ➔ TOT
GAG ➔ AAG
GGC ➔ AGC

Mutation
Residue
CpG Frequency
Type
Mutation
56
No
Glu ➔ Lys Transition
35
Arg ➔ Thr Transversion No
Yes
Ar� ➔ Gin Transition
30
27
Yes
Arg ➔ His Transition
24
Yes
Arg ➔ His Transition
22
No
Arg ➔ Lys Transition
Arz ➔ Trp Transition
Yes
21
19
No
Tvr ➔ Cvs Transition
18
Glu ➔ Lys Transition
No
Transition
Yes
15
Gly ➔ Ser

The TP 53 exon7 extends from codons 235 to 249. 18 The p53 hot spot codons 245,248
and 249 fall within this range. All of the exon 7 bladder cancer point mutations listed in
Table 1 were transitions. The mutations at codon 248 of exon7 were G-C ➔ A-T and
C-G

➔ T-A transitions with 2.7 and 1.9 % respectively,while codon 245 G-C ➔ A-T

transitions were 1 .4 % of the total number of mutations. 14
Another source stated that bladder cancer was dominated by G-C ➔ A-T
transitions and G-C ➔ C-G transversions on TP53. 28 In comparison the transversion
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G-C ➔ T-A accounted for one third of the mutations in lung cancers of smokers and was
associated with the carcinogen benz[a]pyrene (B [a]P), the precursor of activated
benz[a]pyrene diol epoxide (BPDE). 13 In a study of 110 patients with bladder tumors 38
% of the TP53 mutations in smokers were between codons 241 and 249 on exon7. 29
When one dimer of the p53 tetramer is mutant and the other wild-type, the entire
heterotetramer becomes dominant negative. In this way heterozygotes lose p53
function. 27 Without a functioning TP53 gene mutant cells that would normally undergo
apoptosis will remain to increase the frequency of the mutation and thus tumors are not
suppressed. Also p53 malfunction hinders transcription at target genes and thus response
to DNA damage.24 When compared to BPDE formed mutations in the lung, bladder
mutations caused by ABP are more evenly distributed along the gene. 17 Bladder
mutations occur at the CpG hotspots, common to other cancers, i.e. codons 175 and 248.
But they also occur at non-CpG spots such as codons 280 and 285. 18 According to
Professor Soussi with bladder cancer it may not be the TP53 that is mutated, or on the
'other hand because the transitions are "localized predominately outside of the CpG
dinucleotide suggesting a carcinogen is still involved".30 The reasoning was that
mutations at CpG spots are more likely due to spontaneous deamination of 5mC to allow
the C ➔ T transition,24 vide supra.
In murine test subjects for GC ➔ TA transversions BPDE preferred 5mC on the
5' side of a guanine base adduct. N-OH-acetyl-ABP preferred A and T on the 5' side. 5
For the same transversion A was preferred for both BPDE and N-OH-acetyl-ABP on the
3' side. The G-C ➔ A-T transition predominant in p53 human bladder cancer was not
observed in the study5 and was thus a likely cause for Professor Soussi's equivocation.
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Feng et al. indicated the chromatin structure surrounding the p53 genome within a
cell was not to be a factor in the distribution pattern of ABP-DNA adducts when
comparing naked genomic DNA reacted with N-OH-ABP and bladder cells with N-OH
acetyl-ABP. The pattern was determined by the "binding specificity" ofN-OH-ABP and
the "human genomic content."17 In exon 8, ABP-DNA adducts were found clustered
around codons 280 to 285, with codon 280 giving the highest level of adducts (compare
to Table 1). This region contains no CpG sites, except codon 282. ABP adduct
formation was barely detected at codon 273, a CpG site and a major mutational hotspot in
many human cancers including bladder cancer. 17

Metabolic Pathways for 4-Arninobiphenyl
Overview
The ary lamine 4-aminobiphenyl (ABP) in cigarette smoke, or from other sources
is activated in the liver by cytochrome P450 1A2 to the hydroxyl amine N-hydroxyl-4aminobiphenyl (N-OH-ABP).31 In red blood cells (RBC) N-OH-ABP, via a 4nitrosobiphenyl intermediate binds with hemoglobin's sulfhydryl groups of cysteine to
form the hemoglobin adduct ABP-Hb.32 The ABP-Hb adducts persist for up to 4 months
throughout the lifetime of the RBC.32 The ABP-Hb adduct is a biomarker of smoking
exposure but is not in the metabolic pathway towards bladder cancer; rather it is a
detoxification pathway.33
When these ABP-Hb adducts were detected they were statistically related to
bladder cancer risk. 8 Smokers had higher levels of these Hb adducts than non-smokers,
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the ABP-Hb level could be used to determine the recent smoking history of a patient.
Conversely other studies indicated ABP-Hb adducts though in themselves related to
tobacco smoke exposure were only weakly associated with bladder cancer.32 The
correlation to bladder cancer was stronger in women but still only weakly associated.32
Kadlubar et al. and Babu et al. cited others that show up to 5 to 10 % of the ABP given to
rats ended up bound to Hb.33• 34
Jones and Sabbioni performed a series of LC-MS/MS experiments related to
ABP. In vivo they found that rats dosed with ABP had bothN-(deoxyguanosin-8-yl)
ABP (dGuo-8yl-ABP) andN-(deoxyadenosin-8-yl)-ABP (dAdo-8yl-ABP), yet quantified
only dGuo-8yl-ABP. But in vitro, reacting N-OH-ABP with calf thymus DNA (ct-DNA),
the nucleophilic deoxyadenosine produced multiple products not just at the C8
configuration.35 The majority of the literature described the major DNA adduct formed
as dGuo-8yl-ABP comprising 70% of the adducts. 20 % of the adducts formed were
described as eitherN-(deoxyguanosin-N2-yl) ABP (dGuo-N2-ABP) or dAdo-8yl-ABP.36
Yet another citation listed dGuo-8yl-ABP as 80% and dAdo-8yl-ABP as 15% with an in
vitro reaction with ct-DNA. 37 When reactingN-OH-[3 H]ABP with calf thymus three
adducts were observed by the 32P-postlabeling technique. The major adduct was dGuo8yl-ABP but the other spots were not characterized.38 Other manuscripts discussed the
existence of the minor deoxyadenosine adduct as well. 16
Metabolism of 4-Aminobiphenyl
In humansN-acetyltransferases 1 and 2 (NATl and NAT2) performN-acetylation
of ABP, O-acetylation on hydroxyl groups of the P450 1A2 hydroxylated productN-OH-
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ABP and N,O-transacetylation.39-41 NAT2 was cited as found primarily in the liver and
intestinal epithelium whereas NATl was found throughout the human body.40 The P450
I A2 activity (N-hydroxylation) was in competition with the detoxification of ABP by
NAT2.32 NAT2 and NATI both O-acetylated the P450 1A2 product N-OH-ABP to
N-acetoxy-ABP (N-OAc-ABP).
The N-OH-ABP, and to a lesser extent ABP reacted with glucuronic acid in the
liver to form their glucuronides (see Figure 1). In the hepatic microsomal fraction
glucuronides formed. 34 The N-OH-ABP (and ABP) glucuronides travel in the blood to be
passed from the body in urine. But in the mildly acidic urine of pH 5.5 they hydrolyze
back to the unconjugated amine or hydroxylamine.34 These amines were presumed to be
then metabolized by O-acetyltransferases and peroxidases in the bladder epithelium to
form adducts with DNA. 34 The half life of the ABP glucuronide in the bladder was 10.5
minutes at pH 5.5. The half life of the N-OH-ABP glucuronide was 32 minutes, whereas
the N-acetyl-N-OH-ABP glucuronide under the same conditions had a half life of 55
minutes.34 This again indicated that NAT acetylation metabolism tended more towards
detoxification; the latter compound being more likely to pass in the urine and not
dissociate before urination. Acidic urine played some part in the formation of bladder
cancer, but frequency of urination played a greater role in a computer model. When
urination increased from every 8 hours to "continuously", the amount of ABP-DNA
adducts decreased 17-fold.33
In their study Tsuneoka et al., on finding that CYP1A2 knock out mice had more
DNA adducts than CYP1A2 wild-type mice came to the conclusion that the P450 1A2
did not activate ABP.48 Their resolution to this apparent contradiction with the bulk of
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Figure 1. 4-Aminobiphenyl Metabolism in the Human
NAT2* slow acetylation pathway in double arrow above is a detoxification
pathway. 34 Dotted pathways determined by Babu et al. occurred in human liver
microsomal fractions but not human liver slices. 34 Burger and Swaminathan et al.
both reported the existence of dG-N2-4-AABP 42 , 43
Sources: Kadlubar 1987;44 Lasko 1988;'' 6 Bartsch 1993; IO Meyer 1994;4 I Skipper 1994;4-)
Babu 1996;34 Burger 2001;42 Swaminathan 2002;43 Falvey 2004;46 Nakajima et
a l.2006;47
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the literature was that other enzymes metabolically activate ABP namely by the
conjugation with UDP- glucuronic acid by UDP-glucuronide transferase (UGT). Murine
P450 1A2 is peculiar in that, unlike in humans and rats it was not the only P450 enzyme
to activate ABP to the hydroxylamine.49 A somewhat related finding was that in an
Asian human population CYP1A2 status was related to bladder cancer risk. 50 Therefore
studies with mice to determine a human parallel for ABP metabolism were not
recommended.
Nitrenium Cation Intermediate
The labile nitrenium cation forms when the N-OAc-ABP sheds its acetate anion.
It acts as a potent electrophile that is then attacked by nucleophilic sites in DNA.41• 46
The purine C-8 of guanosine in the bladder urothelial lining is the most prevalent reaction
site. Adenine is 10 % as reactive as guanine.46 The mechanism is either of direct
electrophilic substitution at C-8 or an initial adduct with N-7 and then migration to the C8 position.46 Falvey noted that aryl nitrenium ions formed C-8 adducts with free bases
and nucleosides of guanine, but in DNA the N-7 and 0-6 adducts were more prevalent46
which may explain Jones and Sabbioni's observation of a variety of adducts (vide supra)
yet contradicts the evidence that the dGuo-8yl-ABP is the most prevalent ABP adduct. 36•
38• 51

Falvey himself presented an N-7 to C-8 migration mechanism for the ABP

nitrenium ion as did Guengerich et al. to explain the formation of the C-8 adduct.46• 52
Falvey also stated in contradiction that the migration mechanism did not occur in DNA.46
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Other Pathways Related to Bladder Cancer Research
Kadlubar showed that 10 % of the DNA adducts in canine urothelial walls were
from the peroxidation of ABP by prostaglandin H-synthase (PHS). Adducts formed from
PHS peroxidation were different than those from P450 N-oxidation. The remaining 90 %
of the adducts were from N-OH-ABP. 44 Burger suggested other minor adduct formation
by way of reactive oxygen species formed by peroxidases and arylamidonium ions. The
resulting adduct was thought to be 3-(deoxyguanosin-N2-yl)-4-acetylaminobiphenyl (see
structure in box in Figure 1 in the upper right corner) at less than 5 % of the major adduct
dGuo-8yl-ABP.42
N-OH-ABP was known to react in vitro with DNA to form DNA adducts and was
used in studies to simulate the enzymatic pathways. 17' 18• 35• 36• 38• 53 But because of its
excessive reactivity it tended to react indiscriminately.20 Yet in the work of Jones and
Sabbioni it was necessary to extract excess N-OH-ABP prior to further analyses
indicating its persistence.35 Verghis et al. used N-OAc-ABP, the metabolically occurring
intermediate in their study. 15 Besaratinia used N-OH-4-acetylaminobiphenyl (N-OH
AABP).

5

The P450 enzymes associated with genes CYP2A6 and CYP2El Rsa/had no
correlation with urothelial cancer risk in a Japanese population. 54 In another study,
polymorphism in CYP2El was not correlated to bladder cancer.55 CYP2El does take
part in the metabolism of ethanol and acetaminophen, the formation of free radicals from
peroxides and the activation of toxic chemicals like CC14 and N-nitrosamines. 55 The
GSTMnull genotype was associated with a higher risk in bladder cancer regardless of
smoking or detoxification of tobacco smoke.56
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CHAPTER III
CYTOCHROME P450 MECHANISM RESEARCH
Introduction
P450 enzymes are a family of heme-containing proteins. They are named for the
450 nm absorption of their carbon monoxide adducts, therefore are called pigment-450.
Hemoglobin, typical of other heme proteins, absorbs in the presence of CO at 420 nm. 57
The cause of this red-shift in absorbance of P450s is due to the fifth proximal axial
ligand, a thiolate ligand from cysteine whereas in hemoglobin the fifth ligand is histidine.
This thiolate ligand donates electron density to the heme iron. 58
The chemical reactions performed by P450s are: 59 nucleophilic oxidation,
incorporation of OH, incorporation of O and/ or abstraction of H. Sligar called P450s a
"blowtorch". Sligar meant that P450s can accomplish difficult reactions under neutral
pH, mild conditions and in aqueous media.60 P450s are found in mammalian tissues,
insects, plants, yeasts and bacteria. 61
The nomenclature of human P450s is defined by the Human Cytochrome P450
Allele Nomenclature Committee,62 as such: the first number after CYP designates the
family, the letter the subfamily and the second number the particular protein. Those in a
family have> 40 % sequence homology; those in a subfamily have> 55 % homology. 57
The eight human P450 families named on the allele nomenclature website are: CYPI,
CYP2, CYP3, CYP4, CYP5, then CYP8, CYP19 and CYP21.62 In this chapter CYP is
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used to name the human counterpart of other P450s, but in the literature CYP and P450
are generic terms and used interchangeably. 63
Among highly conserved features throughout all P450s are the pair of Thr and
carboxylate residues: Thr 321 / Thr 319 / Thr 252 and Asp 320 / Glu 318 / Asp 251, the
codons for human CYP1A2 I Saccharomyces cerevisiae P450 1A2 / Pseudomonas putida
P450cAM respectively. 64 The diversity of the P450 enzymes lie in the delivery system
used to supply electrons to the P450 active site. 65 P450cAM found in P. putida which 5hydroxylates camphor, uses electrons from NADH through the flavoprotein
putidaredoxin reductase and the iron sulfur protein putidaredoxin. 66 Microsomal human
CYP1A2 from the endoplasmic reticulum uses membrane bound NADPH-P450
reductase with NADPH as the electron source. 67
The P450 1A2 catalyzes the N-hydroxylation of aromatic and heterocyclic
amines,52 the first step in the metabolic activation of these carcinogens. 68 The P450 1A2
is liver constitutive. 69 P450 1A2 was the P450 of interest in this research as it catalyzes
the activation of 4-aminobiphenyl.31 The CYPIA2 is the human P450 counterpart that
catalyzes this reaction and is the dominant enzyme in the N-hydroxylation of arylamines
and heterocyclic amines. 52' 63 The CYPIA2 enzyme catalyzes carcinogen activation,
estradiol hydroxylation70 and metabolic clearance of caffeine, melatonin, and a number of
marketed medications. 63
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Studies on P450 I A2 Compared to P450cAM
Before the most recent release of the structure of human CYP IA2 by X-ray
diffraction crystallography63 no P450 IA2 structure had been determined. The active site
structure of rat liver P450 IA2 was probed instead with phenyldiazene and
biphenylhydrazine to form adducts with the pyrrole rings of the cytochrome heme. 69 The
structure of P450cAM on the other hand was known at that time. Thr 252 and Asp 251 of

--

- .,..

f

Figure 2. P. putida P450cAM Protein Structure
Prepared with Swiss-Pdb Viewer71
Source: PDB ID: 1DZ6, Schlichting et al. The Catalytic Pathway of Cytochrome
P450cAM at Atomic Resolution, Science 2000, 287, 1615-1622
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P450cAM with side chains on the I-helix (the shaded a helix in the center of the lower
right domain in Figure 2) were known to be associated with the active site. Tuck et al.
set out to show how variations of the side chains reflected changes in the ratios of adducts
with the above mentioned phenyl probes.
Tuck et al. accomplished this through mutations of the respective rat liver P450
1A2 Thr 319 and Glu 318 residues.69 The P450 1A2 was observed to give pyrrole ring A
adducts through a phenyl probe when Thr 319 was mutated. These observations were
consistent with those found with Thr 252 mutations of P450cAM but to a greater extent.
Glu 318 mutations in the mammalian P450 caused little change in adducts. The Asp 251
of P450cAM sits in proximity to the heme group but with the intervening Thr 252.
Therefore since Glu 318 mutation, the P450cAM Asp 251 counterpart produced no phenyl
adducts it was concluded to be further away from the pyrrole rings in P450 1A2 as well. 69
Another study performed on S. cerevisiae P450 1A2 showed that mutating Glu
318 and Thr 319 led to changes in dissociation constant, Ki values for R- and S
enantiomeric axial ligands when measured spectroscopically.64 The inference was taken
that Glu 318 and Thr 319 are involved with ligand binding to the heme group.

The Structure of Human CYP1A2
The protein structure 2HI4 of human CYPIA2 has been released in the Protein
Data Bank (PDB).63 For the structure see Figure 3. Note the similarity of the a-helix,
discussed by Tuck et al. 69 named the I-helix shaded in the center of the structure
compared to that of P450cAM in Figure 2. This human CYPIA2 protein was expressed in
Escherichia coli for crystallization.
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Figure 3. Human CYPIA2 Protein Structure
Prepared with Swiss-Pdb Viewer71
Source: PDB ID: 2Hl4, Sansen et al., Adaptations for the Oxidation of Polycyclic
Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2, J. Biol.
Chem. 2007 282(19) 14348-14355
Note the N-terminus in the Swiss PDB Deep View started at Arg 34, not Met 1.
The CYPIA2 protein was expressed for residues 26 to 515 and preceded by Met and Ala.
Additionally nine residues at the N-terminus and six at the C-terminus could not be traced
in the electron density maps of the synchrotron.63 The N-terminus is not necessary for
catalytic activity,59 but gives it its transmembrane binding character. The removal of the
N-terminus of P450 IA2 in the past has not made it soluble enough for crystallization.67
Uniform aqueous or organic solubility is the quality that allows a protein to be
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crystallized. P450cAM is soluble in aqueous solution.72 Sansen et al. were able to
solublize the CYP1A2 protein by expressing it with the chaperones GroEL and GroES. 63
The substrate in Figure 3 represented in stick figures in black was the polyaromatic
hydrocarbon a-napthoflavone and is not to be confused with the iron containing
protophorphyrin IX heme which lies perpendicular to the substrate in the same plane of
the viewer's perspective.63
Sansen et al. described the CYP1A2 active site architecture as being flat and
uniformly narrow, well suited for planar compounds such as those mentioned in the
Introduction of this chapter. 63 The comparison was made with the CYP2A6 active site
due to the similar shape to that of the CYP1A2 active site. But the CYP2A6 active site is
50 % larger. CYP2A6 also oxidizes small planar molecules.63

Kinetic Studies on CYP1A2
In human's CYP1A2 substrate O-dealkylation of 7-ethoxycoumarin, the kinetic
isotope effect of l ,1-d2-ethyl substrates indicated that C-H bond-breaking was the rate
limiting step and not the production of the reactive enzyme-oxygen complex in both
purified P450s and human liver microsomes. 73 Another product of the CYP1A2 reaction
was the result of 3-hydroxylation. Only the dealkylation was studied but in order to
determine if hydroxylation C-H bond-breaking was rate limiting, a deuterated 7ethoxycoumarin at the 3-position would have to have been employed to compare directly
to the P450cAM mechanism of hydroxylation.
In another kinetic isotope effect (KIE) hydroxylation study rabbit P450 1A2 was
investigated.74 The substrates for P450 hydroxylation were 4-nitroanisole, 4-
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cyanoanisole, 1,4-dimethoxybenzene and methacetin. The deuterium KIE ranged from
1.9 ± 0.1 for intermolecular competitive to 14.9 ± 2.1 for intermolecular noncompetitive.
The latter value was high, but KIE values of> 10 in P450 reactions are frequent. In
mammalian P450 1A2 bond-breaking of C-H was rate limiting. In P450cAM when
camphor was the substrate C-H bond-breaking was not the rate limiting step. Only when
C-H bond-breaking became a factor with modified rapidly oxidized substrates was it a
factor. Mammalian P450s in general had slower KIE rates than bacterial P450s in which
quantum mechanical tunneling might occur. Guengerich et al. concluded C-H bond
breaking was the rate limiting step in rabbit P450 1A2 and partially rate-limiting in many
mammalian P450s including human CYP1A2.74
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CHAPTER V
MATERALS AND METHODS
Chemicals
Aniline, 4-aminobiphenyl (ABP), and 8-bromoadenosine were purchased from
Sigma-Aldrich (St. Louis, MO). Tris( dibenzylideneacetone )dipalladium(0) (Pd2(dba)3)
was purchased from Sigma-Aldrich (Milwaukee, WI). Sodium tert-butoxide and tert
butyldimethylchlorosilane were purchased from Sigma-Aldrich (Allentown, PA). (S)-(-)2,2'-Bis(diphenylphosphino)-l ,l'-binaphthyl (S-BINAP) was obtained from ACROS
Organics (Fair Lawn, NJ). US Filter Pure-LabP/us filtered H2 O was used. The filtered
H2 O had a minimum 18 M.Q resistance. The Sprague-Dawley rat liver S-9 fraction from
male rats contained75 0.197 nmol/ mg protein Cytochrome P450 was obtained from
XenoTech, LLC (Lenexa, KS) and stored at -80° C until the time of use. The NADPH
generating system components were D-glucose 6-phosphate disodium hydrate (G6P), P
nicotinamide adenine dinucleotide phosphate sodium salt (NADP+) and 228 units/ mg
solid, with 1.2 mg solid glucose-6-phosphate dehydrogenase (G6PDH) from S.
cerevisiae; all obtained from Sigma-Aldrich (St. Louis, MO). A unit G6PDH converted 1
µmol G6P to 6-phospho-gluconate in 1 minute per Sigma-Aldrich specifications.
Caffeine and paraxanthine were obtained from Sigma-Aldrich (St. Louis, MO). The 45mer TP53 exon7 coding (sense) and transcriptional (anti-sense) single stranded DNA
(ssDNA) were synthesized for these experiments by the Michigan State University-
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Macromolecular Structure Facility (East Lansing, MI). The sequences are drawn in
Equations 1 and 2. The molar absorbtivity coefficient equations were provided from the
ssDNA supplier MSU-MSF.
Equation 1.

Sense Strand Sequence and Molar Absorbtivity Coefficient

AAC TAC ATG TGT AAC AGT TCC TGC ATG GGC GGC ATG AAC CGG AGG
£260

= [(12Ax15,480) + (14Gxl1,760) + (10Cx7340) + (9Tx8850)] x 0.89 =
[503450]x0.89 = 448070.5 (M cm

Equation 2.

r'

Anti-Sense Strand Sequence and Molar Absorbtivity Coefficient

CCT CCG GTT CAT GCC GCC CAT GCA GGA ACT GTT ACA CAT GTA GTT

c26o =.[(9Ax15,480) + (l0Gxl 1,760) + (14Cx7340) + (12Tx8850)] x 0.89 =
[465880]x0.89 = 414633.2 (M cm

r'

Reagents
The buffer for the DispoEq reactions consisted of76 50 mM potassium phosphate
pH 7.4, 3 mM MgCh and I mM EDTA designated as K.Phos. K.Phos was prepared in 2x
concentration to be diluted to Ix by the other reagents prepared in 18 M.Q H20. It must
be noted that in order to autoclave the KPhos to sterilize the solution for preservation and
to remove DNases each component of the buffer was prepared separately, autoclaved,
combined and brought to the mark, in this case of 200rnL. When combinations of
components were combined prior to autoclaving a precipitate formed and the buffer was
useless. The EDTA was added to the DNA to minimize the Fenton Reaction formation
of OH radicals by Fe2+ .
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The NADPH generating system (G.S.) purpose was to provide the reducing
equivalents for the P450 in the S-9 fraction. The G.S. ratios used were approximations of
those recommended by the S-9 supplier XenoTech, LLC76 namely: l mM NADP+, 5 mM
G6P and I unit G6PDH (the G6PDH was prepared in 50 % v / v glycerol). (The initially
advised G.S. ratios were 0.5 mM NADP+, 10 mM G6P and 0.5 unit G6PDH but were
abandoned.77 When the UV spectrophotometer was discovered as the source of
difficulties instead, the original ratios were not resumed).

Equipment
A Mettler-Toledo 3-place balance (Columbus, OH) accurate to I mg was used for
weighing reagents. A Sartorius CP2P microbalance (Gottingen, Germany) was used to
weigh the Adn-8yl-ABP adduct standard. At the maximum 2.1 g weight capacity of the
microbalance it had an accuracy of± 0.005 mg. The infusion for electrospray (ES) mass
spectrometry was performed with a Harvard Apparatus (Holliston, MA) geared syringe
pump calibrated to a 250 µL syringe to deliver 10 µL per minute. The liquid
chromatography tandem mass spectrometer (LC-MS/MS) pump and autosampler were a
Waters Alliance 2695 Separations Module. The MS had a Z-spray electrospray
ionization (ESI) interface to the Micromass Quattro II MS equipped with MassLynks 3.2
software (Milford, MA). For LC-UV-MS/MS method development a Waters 2487
UVNis detector was in-line just ahead of the ESI source. The LC-MS/MS column was a
™

YMC Phenyl 2 x 150 mm (5 µm, 120 A pore size) column. All tubing for method
development was 0.010 inches inner diameter (i.d.). The PEEK tubing after the LC
column was changed for the final analyses to that of 0.004 inches i.d. A Shimadzu
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Prominence LC-UV system (Columbia, MD) with a WatersXterra-MS C-18 2.1 x 50
mm column with 3.5 µm particle size (Milford, MA) was used for the DispoEq and S-9
fraction system characterizations with caffeine / paraxanthine. The DispoEquilibrium
™

DIALYZERS (DispoEq) for ABP activation reactions were obtained from Harvard
Apparatus (Holliston, MA). The final UV spectrophotometer used for ssDNA
quantitation was a Cary-14/OLIS (Bogart, GA). Ultra-micro and semi-micro disposable
BRAND UV-cuvettes (Wertheim, Germany) with 70- 850 µL and 1.5- 3.0 mL fill
volume range used for ssDNA quantitation and G.S. activity checks respectively. Silver
Shield gloves impervious to chlorinated solvents were obtained from Seneca Research
(Penn Yan, NY). A protective lab coat and latex gloves were worn when handling ABP
and ABP adduct materials.

Synthesis of Adduct Standard
Protection of 8-Bromoadenosine by Silylation
The protected tert-butyldimethylsilyl-8-bromoadenosine substrate for the
subsequent coupling reaction was prepared as described in the literature by Schoffers et
al. using an oxygen- and moisture-free Schlenk-line technique.78
A 105° C oven dried 2-neck 50 mL round bottom flask and condenser were
cooled under vacuum. The 8-bromoadenosine (600 mg, 1.74 mmol) and imidazole (946
mg, 13.92 mmol) were placed in the flask. Dimethylformamide (10 mL) and tert
butyldimethylchlorosilane (1050 mg, 6.96 mmol) were added. The flask was sealed with
a glass stopper, put under positive argon pressure and allowed to stir 6 days at room
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Reaction 1. Protection Reaction of 8-Bromoadenosine
temperature. The product was purified by flash column chromatography on 30 mL dry 
packed silica conditioned with 3:1 hexanes / ethyl acetate into 10 cm glass screw top
culture tubes. One row of spots eluted on thin layer chromatography (TLC) at Rf of 0.26.
Tubes 4 ➔ 16 were taken and combined. The final product was characterized by 1 H
NMR Figure 5.
Coupling Reaction of ABP and Silylated 8-Bromoadenosine
The Buchwald-Hartwig coupling reaction was performed as outlined in the
literature by Schoffers et al. 78 Aniline was used as the less toxic arylamine before the
final coupling with ABP. A Schlenk-line was used to exclude oxygen and moisture from
the reaction flask. A 50 mL 2-neck round bottom flask and condenser were heated in a
105° C oven and cooled under vacuum with the ground glass fittings (with the exception
of the glass stopper) wrapped with Parafilm®. The 5 mL glass syringe was placed in a
desiccator to cool. The dry ingredients were passed through the glass stoppered side neck
sequentially in this order: silylated 8-bromoadenosine (40 mg, 0.06 mmol), sodium tert-
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butoxide (9 mg, 0.094 mmol), Pd2(dba)3 (17 mg), S-BINAP (18 mg) and 4aminobiphenyl (31 mg, 0.18 mmol). The S- enantiomer ofBINAP was chosen
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Reaction 2. Buchwald-Hartwig Coupling Reaction
because it had provided a better yield.78 A rubber septum was positioned to replace the
glass stopper and the system was alternately vacuumed and purged with argon three
times, ending with the argon. Anhydrous toluene (5 mL) was injected through the
septum to start the reaction. A preheated silicone oil bath (80° C) was placed under the
flask and the reaction was left stirring under positive argon pressure for 24 hours.
At 24 hours the co-spot TLC method with 5 % methanol / chloroform eluent was
used to determine ifthe reaction had gone to completion. The product had no spot at the
Rr values ofthe starting material and the reaction was considered to have been complete.
A preliminary 1H-NMR spectrum was taken and gave the characteristic terminal proton
ABP doublet signal at 6.19 ppm. (Free ABP has a signal at 6.6 ppm for the same proton).
Flash column chromatography was performed with 30 mL silica slurry packed
with 1 % methanol I chloroform. The product was found to elute in the colored band.
TLC was performed with 5 % methanol / chloroform eluent. The product was in the
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tubes with the Rr 0.24 and 0.28 spots. See Figure 6 for the final 1 H-NMR spectrum and
Table 5 for proton assignments.
Hydrolysis and Purification of Adn-8yl-ABP
The method of hydrolysis and purification of adenosine adducted with 2aminofluorene described by Olsen in his dissertation 79 was used here with adaptation to
yield the N-(adenine-8-yl)-4-aminobiphenyl (Adn-8yl-ABP) adduct. Silylated N
(adenosine-8-yl)-4-aminobiphenyl (3 mg) was dissolved in two aliquots of absolute
ethanol (750 µL) and acidified with another two aliquots 1.0 N HCI (750 µL) in a 4 mL
vial. The vial was heated 1 hr in a H20 bath (75° C). The hydrolyzed adduct was not
neutralized but kept acidic prior to solid phase extraction (SPE) to prevent base catalyzed
hydrolysis of the arylamine-purine bond.80 A Grace-Pure C-18 Low 500 mg bed size 3
rnL SPE cartridge was conditioned with 3 aliquots, 100 % acetonitrile and then with 4
aliquots, 10 % acetonitrile. 81 The sample was loaded onto the conditioned SPE cartridge
and the SPE washed 4 times with the conditioning solvent. The cartridge was vacuumed
to dryness 30 seconds and 5 separate aliquots of eluent were collected with 60 %
acetonitrile. The 100 µL portion from each aliquot eluent collected was diluted l O fold
with 60 % acetonitrile and taken to infusion electrospray MS (ES-MS) for
characterization. A drop formic acid was added to each sample vial to protonate the
analyte for positive mode ES-MS. See Figure 7 for the relative composition of the 5
aliquots. (Use of a latex glove during SPE was found imperative because the Adn-8yl
ABP solution caused delayed sensitive skin irritation).
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A contamination (and likely a decomposition) peak had been observed earlier at
260 nm on LC-UV260/3lo-MS/MS characterization of the sample after its being dried

down. Precautions were taken to shield the adduct standard from excessive heat, light
and oxygen and the oven temperature was reduced from 80 ° to 45 ° C. The contents of
aliquots 1 and 2 were dried down separately with a nitrogen stream in actinic vials and
they were placed in beakers covered with latex gloves filled with argon gas and dried for
16.5 hr in the oven.
Although chloroform was the solvent used consistently to this point, it was
observed that the hydrolyzed adduct was only very minimally soluble in chloroform. See
the LogP values in Table 2. Deuterated methanol was finally used and with success to
solvate the adduct standard. See Figure 8 for the 1H-NMR spectrum in deuterated
methanol of the adduct standard. Figure 9 is the triplicate ES-MS scan of the standard
and Figure 10 is the LC-UV2601310-MS/MS chromatogram of the standard.
A clear 2 mL LC vial was tared repetitively to obtain an average weight. The
contents of the NMR tube were transferred to the vial and dried down under a nitrogen
stream. Once dry, the vial was filled with argon and capped until weighed. The contents
of the weighed vial were rinsed with 100 % methanol into a 50 mL volumetric flask
containing 30 % methanol. The appropriate amount H2 0 was added to give 30 %
methanol and then the flask was filled to the mark. This procedure had been followed
previously with a chloroform extracted adduct standard but because of poor solubility and
the use of a 100 mL volumetric flask a lower concentration check standard was obtained.
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Table 2. LogP Values of Adduct Standard Compared to Solvents
Source: The predicted value of LogP was obtained using the ACD/1-Lab Web service
(ACD/LogP 8.02)

Solvent / Compound

LogP

Chloroform

2.86 ± 0.41

Adn-8yl-ABP

2.80 ± 1.09

Acetonitrile

-0.45 ± 0.19

Methanol

-0.72 ± 0.18

Water

-1.38 ± 0.21

MS Methodology (ES, LC-MS/MS)
Tuning of the ESI Interface Settings
The determination of the proper settings for the electrospray ionization (ESI)
interface was made by infusion electrospray mass spectrometry (ES-MS) run in positive
mode. A solution of polyethylene glycol (PEG) prepared in 50:50 acetonitrile / 1 mM
ammonium acetate was infused to observe the calibration of the MS. PEG has a
molecular ion pattern of [M] = 44n + 18. The sputtering encountered was eliminated by
lowering the desolvation temperature from 200° to 120° C. Other initial tune properties
were: a cone temperature of 120° C, a capillary voltage of 3.20 kV and a sample
methanol composition of 90 %.
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The [M+Ht for the adduct was roughly 303 m/z. Continuum scans were made 6
amu wide from 300 to 306 m/z. To determine the optimum cone voltage, triplicate scans
were made every 3 or 4 volts from 7 to 72 volts. The relative ion count (RIC) maxima
for each scan were averaged for their respective voltages and plotted in Figure 11. To
tune the capillary voltage the cone voltage was set at 48 volts and continuum scans were
made in triplicate every 200 volts for the first few scans and then every 100 volts from
1.60 to 4.20 kV (see Figure 12). The cone voltage was fine tuned at the capillary voltage
setting of 3.30 kV with triplicate scans every 1 volt from 42 to 50 volts (see Figure 13).
All settings were saved as a tune method in MassLynks.
The Waters online protocol for optimizing a multiple reaction monitoring (MRM)
MS method was followed for the most part as prescribed.82 While infusing the adduct
standard solution; the MS 1 , Daughter and MS2 windows were opened in the MassLynks
tune page. The average molecular mass was used for the parent ion mass. After the
completion of the research project the data file for the median optimum scan of the cone
coarse tune was re-processed83 to determine the actual [M+Ht of the parent peak for
MRM (see Figure 14).
Otherwise the MRM was subsequently optimized as described in the online
document as follows: 82 The MS 1 low molecular weight / high molecular weight
(LM/HM) resolution values were lowered to allow more of the parent ion and first
isotope signal showing in the Daughter ion window. The MS 1 resolutions were again
raised to just eliminate the first isotope peak. Finally the MS2 LM/HM values were
lowered to increase the parent ion peak in the Daughter window. The LM/HM final
settings were 13.5 and 12.3 for MS 1 and MS2 respectively.
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To determine the optimal collision energy necessary for fragmentation the
collision energy was first set at 120 volts and the argon collision gas pressure adjusted to
reduce the parent ion centroid signal. Triplicate daughter ion scans were made. The 152
amu daughter ion signal was the major fragment but 153 and 193 amu fragments were
also detected. Triplicate daughter ion scans for collision energies at every 10 then 5 volts
were made from Oto 130 volts (see Figure 15A and Figure 15B). The optimum collision
energy settings were saved as a tune method in the software.
LC-MS/MS Calibration Curve for Analyses
The LC-MS/MS injection volume was 10 µL. Two check standards and the first
3 levels of authentic adduct standard were run singly to verify the accuracy of the setup
before running the 7 levels again completely in triplicate, sequentially from low
concentration to high concentration. A check standard was run between each new
standard level. The minimum of three runs prior to the LC-MS/MS analyses and a check
standard bracketing each triplicate or duplicate data point the analysis protocol
throughout the following stages of the research project.
For the final calibration curve used for quantitation (Figure 17) the solvents were
pipetted first, the proper quantity of adduct standard solution was added but most
importantly the pipette tip of the pipetter was rinsed of adduct to complete the transfer.
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Activation ofABP
DispoEguilibrium DIAL YZERS System
TM

The longevity ofthe generating system (G.S.) was.determined by monitoring
Abs340 ofthe above ratio diluted 1:1 with 2xKPhos to a volume of300 µL in a disposable
ultra-micro cuvette. Figure 20 demonstrates the initial rise and plateau ofthe G.S.
activity. The spectrophotometer used for Figure 20 did not have a working reference cell.
Data readings were taken at circa 1 minute intervals starting at 6 minutes. The first data
point at 1 minute was at was an estimation± 0.1 AU. The activity ofthe G.S. was tested
prior to its use by monitoring a rise in absorbance at 340nm. When using the G.S. with
the S-9 fraction initially for the caffeine / paraxanthine studies and the control studies, the
complete G.S. including the G6PDH was pre-warmed at 37° 3 minutes prior to adding to
the DispoEq tubes. This protocol was revised for the final ssDNA analyses to pre
warming the G.S. substrates for 3 minutes, after that adding G6PDH with mixing and
then pipetting the now complete G.S. to the DispoEq to initiate the final P450 reaction.
The initial recipe of0.75 µL of10 mM G6P with 0.5 units G6PDH would have supplied
a flow ofNADPH for 20 minutes. But the G.S. change to the proportions given by the
supplier limited the NADPH production to only 5 minutes. The biochemical coupling
reaction starting materials and product were nearly the same as those given above in
Reaction 2 in the Synthesis of Adduct Standard subchapter (compare to Reaction 3
below). The difference lies in that by organic synthesis the coupling is via P450 1A2
ABP Activation mediated with a BINAP / palladium catalyst and the brominated C-8
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position of Adn,78 but biochemically ABP undergoes P450 1A2 enzymatic N-oxidation to
N-OH-ABP which eventually reacts to form DNA adducts.84

Sprague/Dawley male rat Liver S-9 fraction 1 mg/mL
NADP + lrnM
G6P5mM
G6PDH lU

K-P04 50mM, pH 7.4
MgCli 3mM
EDTA lmM

37°c

Reaction 3. ABP and Deoxyadenosine Coupling
DispoEq dialysis tubes are constructed with two opposing 75 µL chambers
separated by either a 5 kDa or 10 kDa MWCO membrane. The white-capped end was
arbitrarily designated the Sampling Side and the black-capped end the Reaction Side for
these experiments. The use of Parafilm® to insure water tightness for the 37° C
incubation in the H20 bath caused the DispoEq tube to break in half. It was found on
inspection that no H20 entered an unwrapped DispoEq floating over the weekend in the
H20 bath. Therefore the manufacturer's statement that they were leak proof was
substantiated. Table 3 indicates the setup proportions used for the result reactions of this
research.
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Table 3. DispoEq Setup for ABP Activation and Reaction with DNA

Analysis 1-2 - Reaction of ABP/TP53 exon7 sense strand
Reaction Side - Black
Sampling Side - White
37.5ul 2xKPhos
12. lOuL (25.6 pmol ssDNA) in 2xKPhos
7.5uL 200ppm ABP
25.4uL 2xKPhos
7.5µL S-9 Fraction
37.5µL 18 Mn H20
22.5uL G.S.
Analysis 2-2 - Reaction of ABPITP53 exon7 anti-sense strand
Reaction Side - Black
Sampling Side - White
37.5uL 2xKPhos
5.94uL (24.6 pmol ssDNA) in 2xKPhos
7.5uL 200ppm ABP
31.6uL 2xKPhos
7.5µL S-9 Fraction
37.5µL 18 Mn H20
22.5uL G.S.

The ABP and the S-9 fraction 7.5 µL volumes were pipetted with a P-100
pipetter. It was determined with 15 sequential pipettings of 7.5 µL H2O that the RSD
was± 3 % for the P-100. The ssDNA solutions were pipetted with a P-20 and the
remaining solutions with an R-200 pipetter. All weighings were verified against
standardized weights.
Characterization of the S-9 Fraction
For the purpose of determining the P450 1A2 activity of the S-9 fraction the
caffeine/ paraxanthine transition was characterized. The caffeine/ paraxanthine HPLC
method was performed and adapted from Furge et al. to work on the Shimadzu LC-UV
system.85 The run time for the isocratic 200 µL/ minute method was 6 minutes and the
UV detection was set for 260 nm. The mobile phase composition was 92 % (10 mM
ammonium acetate; 2.5 % acetic acid) / 8 % acetonitrile. See Figure 21 for the
chromatogram. The elution order on this column was reverse of that demonstrated in the
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Furge et al. reference. 85 Separate parallel LC methods with separate calibration curves
were created for caffeine and paraxanthine. If a unified method in the Shimadzu Classic
VP software were desired it required that the standards be mixed in the same LC sample
vial for a composite injection. The retention time windows for caffeine and paraxanthine
were verified on each day by injection of the high point standards (4.0 ppm and 8.32 ppm
for paraxanthine and caffeine respectively).
The DispoEq protocol was performed as in Table 3 for the caffeine / paraxanthine
S-9 characterization. In this case ssDNA was not present on the Sampling Side and 7.5
µL 240 ppm caffeine was placed on the Reaction Side (with and without the 7.5 µL ABP
present). The DispoEq tubes were incubated for 1 hour in the H2 0 bath at 37° and
transferred for the remainder of the 24 hours to the rotating stir tray in a 37° convection
oven. In the final 150 µL DispoEq volume after full equilibration there was 12 ppm
caffeine possible on the Sampling Side.
The 240 ppm caffeine was prepared as a solution in 10 % ethanol. The order of
additions was altered such that the caffeine was added to the 37.5 µL 2xKPhos and then
the S-9 was added to the newly diluted 1.67 % ethanol solution. This was to prevent the
outside chance that the ethanol was precipitating the S-9 proteins essential for reaction.
The reference provided by XenoTech, LLC the S-9 fraction used methanol as a solvent
for a P450 substrate and documented it did not decrease enzyme metabolism at levels of
up to 2 % methanol.86
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Control Studies
The inhibition of the S-9 fraction by ABP was tested by inhibition of the caffeine
/ paraxanthine transition in the same manner in which the S-9 fraction itself was
characterized. In addition 7.5 µL of 200 ppm ABP was added to the Reaction Side of the
DispoEq (to give an overall final 10 ppm ABP in 150 µL for the protocol) along with 7.5
µL caffeine solution.
For the ssDNA analyses the DispoEq tubes were incubated for 1 hour at 37° C in
the H2O bath, agitating them ca. every 10 minutes to insure adequate mixing of the
contents on the Reaction Side. An additional 23 hours was spent on a rotating gravity stir
tray in a 37° C convection oven (the digital temperature setting had been verified by a
thermometer placed on the shelf inside). The former incubation was to insure adequate
heat transfer during the G6PDH production of NADPH. The latter 23 hours of
incubation was to allow proper agitation for dialysis. The contents of the Sampling Side
were quantitatively removed to respective 1.8 mL actinic screw topped vials (with septa)
containing 75 µL 60 % methanolic 0.1 N HCl / 40 % 1.0 N HCI. The resulting
composition was 30 % methanol in the vial. The vials were suspended in a rack for 2
hours in a 75° C H2O bath. These were the hydrolysis conditions for the Control Studies.
The acid composition was changed to 100 % aqueous for the final analyses, i.e. 75 µL 1.0
N HCI. This change was made to insure a more quantitative transfer of adduct, its being
more soluble in H2O relative to methanol (see LogP Table 2).
The final control study undertaken was to determine if ABP reacted to form an
adduct with ssDNA in the absence of the S-9 fraction. Concurrent 48 and 24 hour
duplicate DispoEq incubations were performed with non-calibrated sense strand DNA in
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the Sampling Side and G.S. / ABP on the Reaction Side. The concept for both the final
control study and the later final analyses was that the ABP would be transformed by the
S-9 into the reactive N-OH-ABP on the Reaction Side in the first hour and then traverse
the membrane during the remaining 23 hours (here also 47 hours) to react with ssDNA
restricted to the Sampling Side by its larger MW. In this particular control study the S-9
was absent.
The amount of ssDNA used on the Sampling Side was a 37.5 µL aliquot of the
lyophilized amount supplied from MSU-MSF in a microfuge tube reconstituted with 300
µL 2xKPhos and heated at 37 ° C in the H20 bath. (This dilution and heating became the
protocol for reconstituting the ssDNA). The G.S. and ABP were placed on the Reaction
Side and the DispoEq was placed in the H20 bath for 1 hour at 37° C. The first duplicate
DispoEq were agitated on the rotating gravity stir tray in the 37° oven for another 47
hours. After 24 hours into the first sample's incubation / agitation, the second pair of
DispoEq were placed in the H20 bath for 1 hour incubation and transferred to the stir tray
in the oven for the remaining 23 hours. In the first run of this control experiment the
hydrolysis was performed in methanolic HCI. The experiment was repeated under
similar conditions but with 1.0 N HCl hydrolysis for 24 hours (but not 48 hours). The 1.0
N HCI hydrolysis became protocol with the subsequent ssDNA analyses. The resulting
LC-MS/MS chromatograms are shown in Figure 23.
In an attempt to explain the retention time change of the Adn-8yl-ABP adduct
produced in the DispoEq tubes compared to that of the adduct standard as was used for
calibration, the 1195 pmol / µL sense strand DNA was spiked with 86.1 ng / 10 µL
adduct standard. The thymine was also spiked with adduct standard. The amount of
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thymine used was equivalent to the 9 thymidine in the sense strand DNA, namely 10.8
nmol / µL. The thymine was spiked at low (check standard) and calibration curve (high
point) levels of Adn-8yl-ABP. See Figure 25 and Figure 26 for the chromatograms of the
Adn-8yl-ABP spikes of DNA and thymine respectively. If Watson-Crick hydrogen bond
pairing was the cause of the prolonged retention times for the adducts in the DispoEq
analyses it was expected that the thymine spiked with standard would also have eluted
later. It was also expected that the three peaks between 9.8 and 11.0 minutes in the DNA
spike chromatogram were the relative concentrations of the match and mismatch base
pairing with the Adn adduct, i.e. A-T>GA> AA as is mentioned in the Computational
Determinations subchapter.

Final Laboratory Analyses
For the final analyses lyophilized sense and anti-sense ssDNA (coding and
transcription respectively) in microfuge tubes was reconstituted as per the protocol
discussed in the Control Studies subchapter with 300 µL 2xKPhos. The Abs260 readings
were taken with the Cary14/OLIS (Bogart, GA) spectrophotometer to determine the
concentration of DNA using Equation l and Equation 2 for the respective strands. The
dilution ratios necessary to provide equivalent 5 pmol I µL ssDNA in the eventual 75 µL
on each Reaction Side of the DispoEq were determined. See Table 4 for the Abs260
readings taken to verify the volumes used. The LC injection volume was 10 µL.
After 24 hours in the DispoEq the 75 µL were diluted 1: 1 with 1.0 N HCl for 2
hours of hydrolysis and taken to the LC Column. The two DispoEq tubes for each of the
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TP53 exon7 sense and anti-sense strands were themselves run in duplicate by LCMS/MS.
Table 4. Quantitation of ssDNA Strands at Absorbance 260 nm
lP53 exon7 Sense Strand
PRK 1C - 12.10µL to 300µL for Abs260 /\N 1"2.10µL to DispoEq
pmol/µL
pmol/µL in DispoEq
pmol max. on Column
Abs260
E260
25.6
5.12
1.279
0.573
070.5
448

I
I

I
I

I
I

I
I

lP53 exon7 Anti-Sense Strand
PRK 2D - 5.94µL to 300µL for Abs260 /\N 5.94µL to DispoEq
pmol/µL
pmol/µL in DispoEq
pmol max. on Column
Abs260
E260
2 4.6
1.232
0.511
4.93
414633.2

I
I

I

I
I

I

I

I

Computational Determinations
Visua!OMP6.0 Software Application
The computational determination of the secondary structures of the sense and
anti-sense strands was performed with Visua!OMP6.0 at DNA Software, Inc (Ann Arbor,
Ml). Visua!OMP6.0 (oligonucleotide modeling platform) uses Watson-Crick base pair
nearest neighbor parameters for its calculations derived from an experimental dataset
compiled from multiple laboratories. The database of thermodynamic parameters
includes structures such as Watson-Crick base pairs, internal mismatches, terminal
mismatches, terminal dangling ends, hairpins, bulges, internal loops and multibranched
loops.87
Visua!OMP6.0 was developed to assist in DNA polymerase chain reaction (PCR)
primer design. 88 For PCR Visua!OMP6.0 not only optimizes more accurately the melting
temperature (Tm) of oligos than other primer design software, but optimizes the annealing
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temperatures for the highest percentage oligo binding as well. Input parameters
necessary for Visua!OMP6.0 are the concentration of each oligo, the magnesium ion
content and the total concentration of monovalent ions (sodium, potassium and
ammonium ions combined). VisualOMP did not as of 2004 have the capability to
account for calcium ions such as would be necessary wit_h in vivo simulations.87 The
computational determinations have been shown accurate in the range of 0.05 to 1 M
sodium ion.87 The input values for the TP53 exon7 folding computations were: 0.333 µM
+
concentration ssDNA, 37° C temperature, 91 mM K monovalent ion and 3 mM for the
+

Mg ion. (The lxKPhos buffer was 50 mM at pH 7.4 which gave a K+ ion concentration
of 91 mM). The following progression is the order of decreasing pairing strength as
determined in the database:

87

G-C> A-T> GG> GT:::. GA> TT:::. AA> TC:::. AC:::. CC.
G was described as being a promiscuous base, binding with most any other base. 87
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ONA Triloop at Codon Arg 248
Recall from Chapter III that Arg 248 is the codon of the DNA binding domain
that contacts the consensus sequence of target DNA in the minor groove. The folded
sense strand of TP53 exon7 as seen in Figure 29A contained a three base hairpin loop
from 041 to A43 in the form of ONA, where N was any p·ossible nucleotide. (The codon
Arg 248 was C40, 041 and 042). This type of hairpin of three has been found to be
especially stable and was given a computational stability bonus in the calculations.87 The
free energy �G and enthalpy �H for the sequence CGGAG were -2 and -2 kcal/ mo!
respectively at 37° C in 1 M NaCl.87 (When GGNAC or CGNAG were the nucleotide
combinations flanking a triloop, the bonus was -2 kcal/ mo! and when AGNAT or
TGNAA it was -1.5 kcal/ mol. 87)
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CHAPTER VI
RESULTS
Adduct Standard Synthesis Results
Pure protected 8-bromo-adenosine was isolated in 83 % yield as seen in the 1H
NMR spectrum (see Figure 5).
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The refined yield for the protected Adn-8yl-ABP adduct standard was 10 mg (22
% yield). See Figure 6 for the 1H-NMR spectrum and Table 5 for the proton
assignments.
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Figure 6. 1H-NMR Spectrum of Silyl-Protected Adn-8yl-ABP
Table 5. Proton Assignments for Figure 6.
D
E
F
K
B
G
Group
C
A
ppm Shift 8.23 7.74 7.59- 6.17 5.20 4.87 4.28- 0.95- 0.163.89 0.73 (-)0.31
7.25
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See Figure 7 for the relative composition of the 5 SPE aliquots to purify the
adduct standard. Aliquots I and 2 were used in Authentic Standard preparation.

C-18 Low SPE Bution of Adn Adduct

(.)

3500000
3000000
2500000
2000000
1500000
1000000
500000
0

-+-Adn-8yl-4ABP 303m'z
--- Contam. - Highest RIC

2

3

4

5

Aliquot from C-18 Low SPE

Figure 7. ES-MS Aliquot RIC Comparison
The LC-UV260/310-MS/MS characterization chromatograms showed no UV260
1
contamination for the prepared authentic standard. See Figure 8 for the H-NMR
spectrum in deuterated methanol and Table 6 for the proton assignments of the standard
used to calibrate the MS. The shift at 4.87 was a water peak and at 3.31 ppm in Figure 8
was the deuterated methanol solvent signal. The solvent shift reference values originated
from PalmOne software.89
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Figure 8. 1 H-NMR of Adn-8yl-ABP Authentic Standard
Table 6. Proton Assignments for Figure 8.
Group mm Integration number protons Shift (ppm)
1
A= br s
10
8.14
B=? Exchangeable?
?
?
C=? Exchangeable?
?
?
4
43
D=s
7.65
2
E=d
25
7.60
2
24
7.42
F =t
11
1
7.31
G=?t
K=? Exchangeable
?
?

D
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In the Spectral Database proton A on adenine was low and broad at 12.8 ppm.90
In the assignments by Schoffers et al. on the silylated compound, proton C was described
as a singlet but not broad and was also not broad in the previous Figure 8. Therefore the
signal at 8.14 ppm was determined to be proton A. In the literature proton B was
suspected to be an exchangeable proton due to pKa changes in adducted dsDNA.91 K was
also exchangeable and not apparent in the 1 H-NMR spectrum because methanol was the
solvent. Proton C was also suspected as exchangeable. Although the neighboring F
protons should have been equivalent, G was a triplet and not a doublet as was seen with
D of the previous Table 5. The D proton of Table 5 corresponding proton G was at 6.17
ppm and more up field. The use of DMSO as an NMR solvent would have given a more
resolute 1 H-NMR spectrum but would have been terminal as far as subsequent use. More
confirmation towards the ID of the authentic adduct standard came from the infusion ES
MS spectrum which had the appropriate [M+Ht centroid signal at 303 m/z. seen below
in Figure 9 and the UV normalized larger 310 nm vs. 260 nm LC peak shown in Figure
10 (see also Figure 16 and accompanying discussion).
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Figure 10. LC-UV260131o-MS/MS Chromatogram of the Adn-8yl-ABP Authentic
Standard
The weight of the adduct standard to be diluted was 0.430 ± 0.009 mg and the
concentration adduct in the 50 mL 30 % methanol in the volumetric flask was 86 ± 2 ng /
IO µL neat LC injection volume. ln determining the precision of the LC authentic
standard and its influence on the calibration curve, only the error in weighing was taken
into account and not from any other real sources such as the volumetric flask, the
pipetters and the LC syringe injection loop.
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MS Methodology Results
For the [M+Ht range of 239 to 591 m/z, the analysis range of this research, all
the PEG centroid signals were observed. Before the final pure Adn-8yl-ABP adduct was
isolated for weighing and LC-MS/MS calibration the ES was tuned. Ion suppression and
ion enhancement by DNA hydrolysis products in the LC-MS/MS analyses were
minimized by the inherent characteristics of LC separation. The adduct standard alone
eluted at 70 % methanol or the activated ABP product with DNA eluted at 100 %
methanol (see Chapter VII). The steps necessary to tune the ES-MS were: cone voltage
coarse tuning, capillary voltage tuning, cone voltage fine tuning and collision energy
tuning. Triplicate MS scans were averaged for each voltage setting. The maximum
coarse cone voltage RIC was at 48 volts. See Figure 11 for the coarse cone tune
maximum RIC scans.
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Figure 11. Coarse Cone Tune to Adn-8yl-ABP, Maximum 48 Volts
The optimum capillary RIC intensity was achieved at 3.30 kV.
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The optimum capillary voltage was 44 volts.
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Figure 13. Cone Fine Tune to Adn-8yl-ABP, Maximum 44 Volts
With the cone and capillary voltage at 44 volts and 3.30 kV respectively the
extractor was optimized to 7 volts while the Source RF Lens and Lenses 6, 8, and 9 were
optimized to their response on the tune page scope of the MS. The average molecular
weight92 of 302.3396, plus a proton was chosen as the parent peak for the adduct standard
i.e. 303.3 mlz for the Daughter window. After the completion of the research project the

data file for the median optimum scan of the cone coarse tune was re-processed83 to
determine the actual [M+Ht of the parent peak 303.1 m/z for MRM (see Figure 14).
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Figure 14. Molecular Weight of the Parent Peak
Having used the [M+Ht derived from the average mass or 303.3 m/z instead of
the monoisotopic mass 303.1 mlz for LC-MS/MS incurred a slight loss of sensitivity.
The span was set at 0.60 amu to allow the passage of the parent peak. Thus only 303.00
to 303.60 mlz were allowed to pass. The full trailing portion of the parent signal was
allowed to enter the MS2 quadrupole, but the leading edge of the peak was excluded for
the most part. The full sensitivity potential for MRM mass spectroscopy was not realized
in this research due to this fact. But the use of a narrow span disallowed the passage of
the [M+Ht signal 304.1 mlz of another possible adduct, N-(guanine-N2)-ABP with the
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similar but different transition of 304.1

➔ 152 mlz.

Note this point for Table 11

presented in Chapter VII. The optimum collision energy of 90 volts for the 303.3 ➔ 152
m/z MRM transition was used for the LC-MS/MS calibration and further analyses.

Collision Energy Tuning for Daughter Ions of 303.3m/z
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Figure 15A. Collision Energy Tuning to Daughter Ion Fragments

H

H
H

FW = 302.3

Figure 15B. Parent Molecule and Daughter Ion Fragments of Adn-8yl-ABP
For LC method development the UV wavelengths of 260 and 310 nm were
monitored as well as the MRM 303.3
absorbs at 260 nm. 9'

➔ 152 mlz transition (see Figure 16).

DNA
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Figure 16. LC-UV2601310-MS/MS Chromatograms for Method Development
The 310 nm wavelength is the characteristic absorbance of aromatic amine-substituted
DNA species.15 The LC gradient was characterized and the initial calibration curve
(Figure 19) was determined as linear throughout the calibration range of 1.3 to 86 ng
adduct on the column (with the exception of a dip to the 10.8 ng calibration point). The
injection volume was l O µL. The Savitzky-Golay method of moving quadratic
smoothing of chromatograms was performed. Variations in peak shape would have been
undesirably minimized by the moving means method of smoothing.
For the final calibration curve the LC parameters were optimized to obtain the
best MS sensitivity and reduce the 32 minute chromatographic run times. The UV
detector was no longer necessary and was removed from the flow path. The column was
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placed in a column heater set at 35° C to raise its temperature above ambient. The result
of which was a 27% increase in peak height for the 86 ng high point and a reduction of
37.5% in run time to 20 minutes. See Table 7 for the final mobile phase gradient.
Table 7. Optimized Mobile Phase Gradient for LC-MS/MS Analyses
Run Time in Minutes % Methanol in H2 0 (and 0.2% Formic Acid)
0➔7
30% ➔ 100%
7 ➔ 10
100%
10 ➔ 13
100% ➔ 30%
13 ➔ 20
30%
The calibration curve (Figure 17) established for the quantitation of adenine adducts
formed by S-9 fraction activation of ABP to react with TP53 exon7 ssDNA had a
coefficient of determination of R2 = 0.995684 and the equation y = 1447.20 x with forced
zero. The value for the calibrated check standard was 5.9 ± 0.3 ng I l0µL, n = 8. The
pipetting for the adduct standard concentrations was the critical factor in the residuals of
the calibration curve.
Starting with 86 ng I 10 µL the adduct standard solution was pipetted with an R200 pipetter for the highest 4 levels. The transition was made to a P-20 pipetter for
pipetting the remaining 3 lower levels. The peak height was used to quantitate because
LC-MS is a concentration dependent detection compared to other mass-dependent MS. 94
Therefore fluctuations in flow would not alter response as they would if peak area were
to be used to quantitate. The peak height of one of the low points for the calibration
curve is shown in the Figure 18 chromatogram and was 1.95£03 RIC. This compared to
the peak heights of the adduct (n = 4, p = 0.10) in the final analyses of 58 ± 21and 99 ±
37 RIC for the sense and anti-sense strands respectively.
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Figure l 8. Lowest Calibration Point Chromatographic Peak Height
[n the first calibration curve established (Figure 19) the standard contents of the
R-200 were simply expelled and the tip not rinsed. The negative dip in the plot of the
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residuals in Figure 19 at the lowest volume of the R-200, the I 0.8 ng level gave evidence
that the pipetter was 'To Contain' and not 'To Dispense'. To avoid this systematic error
in pipetting, the analyte of interest was pipetted last and rinsed form the tip with the
solvents.
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Figure 19. Preliminary Calibration Curve

ABP Activation Results
The duration ofNADPH production by the G.S. was determined. The G.S. was
essentially spent in 60 minutes (see Figure 20).
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Figure 20. Longevity of the Generating System
The RSD for 15 sequential pipettings of 7.5 µL H20 with the P-100 pipetter was
determined as± 3 %. This was the pipetter used to pipette the S-9, the caffeine and the
ABP solutions. When checking membrane permeability it was assessed by LC-UV
analysis that only 8 % of the caffeine passed through a 5 kDa MWCO membrane and 57
% passed a 10 kDa MWCO membrane in 24 hours. The latter membrane was chosen for
these experiments.
As Figure 21 indicates the amount of paraxanthine generated from caffeine by the
S-9 was too little to be integrated for quantification. There was a perceptible peak in the
retention time window for paraxanthine. Because of this peak it was concluded that the
S-9 fraction did indeed contain P450 1A2 and it was active to some extent. From the 7.5
µL 50 mM G6P present in the DispoEq system and 1 unit G6PDH, the NADPH G.S. was
calculated to only have 5 minutes duration for the caffeine experiment and subsequent
ssDNA experiments.
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Figure 21. LC Chromatographic Characterization of S-9 Fraction
To determine if ABP inhibited the G.S., ABP levels of 0 ppm (control), 1 ppm
and 20 ppm were used in the cuvette while performing the G.S. check. There was no
observable trend between the levels of ABP (see Figure 22). Because the results were
comparable for the control, l and 20 ppm levels with little difference, ABP was
concluded not to inhibit the G.S. at these levels.
The LC-UV26o chromatograms were indistinguishable with and without ABP. It
was concluded the ABP did not perceptibly inhibit P450 1A2 of the S-9 fraction. The
transfer RSD of duplicate vials of adduct spikes measured by LC-MS/MS of 100 %
aqueous contents were 9 %, 3 % and 2 % for peak heights averaging 92, 14 79 and 22,803
total ion counts respectively. The lowest peak height of the three was for adduct standard
'hydrolyzed' without any thymine nucleoside.
It was postulated that the adenine ofNADP+ may be labile towards attack by the
activated ABP. But the LC-MS/MS chromatograms of the hydrolyzed Sampling Side
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Figure 22. ABP Non-Inhibition of G.S. Testing Results
contents after 24 hour incubation of the S-9, G.S. and ABP together, without ssDNA
+
were unremarkable. It was concluded that ABP and NADP did not react with each other

under these conditions to form an adduct.
The final control study undertaken was to determine if ABP reacted to form an
adduct with ssDNA in the absence of the S-9 fraction. The findings of this control study
were neither as expected nor were the results completely understood. The resulting LC
MS/MS chromatograms are shown below in Figure 23. It was expected that the S-9
would be essential to activate the ABP to react with the ssDNA, but this was apparently
not the case. The retention time for the adduct standard was in the neighborhood of 5.6
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minutes when the calibration curve was established (see Figure 18). The retention time
for the unique to the Adn-8yl-ABP adduct 303.3 ➔ 152 m/z transition varied for the
different experiments of this final control test. With an undetermined amount of sense
strand DNA and methanolic HCI hydrolysis the retention time for 24 and 48 hours
agitation in the DispoEq ranged from the multiple peaks at 2, 9 and 11 minutes and a
single peak at 2.4 minutes respectively for the agitation time (see Figure 23). (24 hour
agitation: 9.91 minutes, 26 ± 6 ng on the column (n = 4, p = 0.10), 2.40 minutes, 0.72 ±
0.14 ng on the column (n = 4, p = 0.10) and 11 minutes not quantitated; 48 hour agitation:
2.41 minutes, 1.26 ± 0.04 ng on the column (n = 2, p = 0.10)). With a 1.0 N HCI
hydrolysis and 24 hour agitation an equal concentration sense strand DNA as was used in
the final analyses resulted in a 2.9 minute retention time (see Figure 24). (24 hour
agitation: 2.89 minutes, 0.13 ng on the column (n = 2, p = 0.10)) For the results obtained
without S-9 fraction ABP activation see Table 8 (compare to Table 10).
After finishing the ssDNA analyses it was investigated if the adduct may Watson
Crick base pair with its complementary thymine present in the hydrolyzed DNA yet
Table 8. LC-MS/MS Results without S-9 Activation
TP53 exon7 Sense Strand (25.6 pmol) without S-9
p = 0.10 n = 2
ng / 10µL Injection Volume
0.13 ± 0.03
17.9 ± 5
fmol Adduct on Column
16 ± 4
mol Adducts per E06 mol nuclec
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Figure 24_ Chromatogram of 25.6 pmol ssDNA, ABP and No S-9 Fraction
disassociate in the ES of the MS to allow the proper MRM transition. It was proposed
base pairing may have been the cause of the observed prolonged retention time seen in
the ssDNA analyses and in one of the control study chromatograms in Figure 23 when
compared to the synthetically prepared standards_ The longer retention time could not be
duplicated with thymine of an equivalent molar amount as in the sense strand DNA of the
final analyses. The thymine/ Adn-8yl-ABP hydrolyzed solution retention time was 5.9
minutes and comparable to the retention time of the calibration adduct standard alone.
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The recoveries of the adduct were 125 % and 138 % for 5.9 minutes and 9.8
minutes respectively. This was an increase of 10 %, or within the range of the confidence
limits of the final analyses relative to the final results. The LC column for the thymine
tests was at ambient instead of the previous 35° C as was the case with the calibration
standard and all of the final analyses. For the comparison of conditions between the
DNA and thymine spikes See Table 9.
Table 9. Conditions Comparison for Adn-8yl-ABP Spikes of Sense Strand DNA and
Thymine
Spike of Sense Strand DNA
Spike of Thymine
ssDNA cone. = 1,195 pmol/µL in 2xKPhos Thymine cone. = 10,800 pmol/µL in 2xKPhos
Spike cone. = 86.1 ng/10 µL in 30% MeOH Spike cone. = 86.1 & 5.9 ng/10 µL in 30% MeOH
Hydrolyzed 1: 1 in 1.0 N HCI 2 hr at 75 ° C
'Hydrolyzed' 1: 1 in 1. 0 N HCI 2 hr at 75 ° C
°
HPLC column at 35 C
HPLC column at ambient
ES capillary same as on calibration
ES capillary cleaned prior to chromatography

See Figure 25 and Figure 26 for the chromatograms of the Adn-8yl-ABP spikes of
DNA and thymine respectively.
DNA-A PRK ID - Am-ltjl-41>.BP Adduct Spike
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Figure 26. Chromatograms of Thymine - Spiked with Low and High Levels of Adn-8yl
ABP Adduct Standard

Final Analyses of DNA Adduct Formation
The signal to noise ratio (SIN) was 2 for the adduct LC peaks. These peaks were
5 % of the low point on the calibration curve (Figure 17). See Figure 27 for the
chromatograms of the final analyses.
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Figure 27. LC-MS/MS Final Chromatograms
The retention times of the final analyses were verified by comparing with
analyses performed at higher concentrations of the sense and anti-sense strands. Figure
28 shows the chromatograms for the 5975 and 359 pmol ssDNA on the column of the
sense and anti-sense strands respectively. Because the DNA concentrations of the sense
and anti-sense strands in the verification analyses were not in parity, their quantitative
results could not be used for comparison with each other. Their peaks along with those
of the Adn-8yl-ABP standard spike of DNA (Figure 25.) did prove valuable to designate
the retention time of the peaks used for quantitation in the Figure 27 chromatograms.
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Figure 28. Chromatograms of Sense and Anti-Sense Strands with Unequal
Concentrations
The results for the duplicate LC vials for each strand, run each in duplicate by
LC-MS/MS were given in Table JO_ It was noted that the sense strand, the coding, the
non-transcriptional strand had fewer Adn-8yl-ABP adducts than the anti-sense,
transcriptional strand (p = 0.10). See Chapter VII.
The 'fmol on the column' values in Table 10 were not rounded to the appropriate
one significant Figure 2ut the 'mol Adducts per I 06 nucleotides' end results were
rounded. The quantitated entity was mo! of Adn-8yl-ABP adduct but corresponded
directly to the desired result of mol N-(deoxyadenosine-8yl)-4-aminobiphenyl (dAdo-8ylABP). The 90 % confidence interval levels were calculated in order to give a significant
difference using a pooled sample deviation_
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Table 10. LC-MS/MS Results

TP53 exon7 Sense Strand (25.6 pmol}
p=0.10 n=4
0.04 ± 0.01
ng / 10µL Injection Volume
finol Adduct on Column
5.7 ± 2
mol Adducts per E06 mol nucleotides
5± 2
X

TP53 exon7 Anti-Sense Strand (24:6 pmol)
X
p = 0.10 n = 4
ng / 10µL Injection Volume
0.07 ± 0.03
10.2 ± 4
finol Adduct on Column
mol Adducts per E06 mol nucleotides
9 ± 4

The value for the check standard when the calibration curve was established as
5.85 ± 0.08 ng on the column (n = 8, p = 0.10) and at the time of the final analyses the
value was 3.55 ± 0.44 ng on the column (n = 7, p = 0.10). The concentration of the check
standard against the calibration curve was a constant throughout the quantitation, acting
as a reference value through system optimizations. Because the sensitivity of the ES
detector was decreasing, the final results were actually greater than shown in Table 10.
To correct for this change the check standards could be used to approximate a correction.
The propagation of uncertainty was done through calculating relative error. The
corrected results were 8 ± 37 % and 15 ± 43 % for the sense and anti-sense strands
respectively.

Computational Results
Figure 29A and Figure 29B were the results of the computational calculations for
TP53 exon7 sense and anti-sense strands respectively. Internal single mismatches such as
the GA mismatch (Figure 4) in the hairpin of the folded anti-sense strand in Figure 29B
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may occur. The bases that were found in Watson-Crick base pairs, as well as the GA
mismatch were much less reactive because of their lower energy state compared to the
unpaired bases. 95 Therefore on the sense strand in Figure 29A there were 8 dA (from the
5' end: l-2-5-7-13-37-38-43) and there were 9 dG ( l 1-17-23-28-29-31-32-41-42)
available for reaction. On the anti-sense strand shown in Figure 29B there were 5 dA
available (20-34-36-38-42) and 4 dG (16-31-40-43) for reaction with activated ABP. It
was computationally determined that the total number of purines available for reaction on
the sense strand was greater than on the anti-sense strand. Further, the ratio of available
dA to dG on the sense strand was less than on the anti-sense strand. These observations
corroborate the experimental evidence that there was less Adn-8yl-ABP found by LC
MS/MS in the DispoEq anti-sense strand compared to the sense strand reactions.
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Figure 29A. TP53 exon7
Folded Sense Strand

dG (37.00'C)= -3.76 kcal1mole
dH= -53.73 kcal mole
dS = -161.12 calimole K
Tm= 60.34'C
[mono•;alent]= 0.0910 mol l
[-\·Ig2-,-]= 3.000e-003 mol:l
1

1

Figure 298. TP53 exon7
Folded Anti-Sense Strand

Structures Determined Computationally with Visua!OMP6.0, DNA Software,
Inc., Ann Arbor, Ml
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Figure 30 shows the stacking of the purine bases in the triloop as generated by the
RNA-123 Software Suite (Ann Arbor, MI).

Figure 30. Tri loop at the Arg 248 Hotspot Codon of TP53 exon7
The Emphasis is on the C-8 Carbon of A43, Loop is 5' to 3' Right to Left
Prepared with Swiss-Pdb Yiewer71
Source: Saro, P. and Santalucia, J., Jr. (2008) "The RNA-123 Software Suite"
(unpublished results)
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CHAPTER VII
DISCUSSION
Control Studies
One could ask whether N-OH-ABP being highly reactive does remain stable long
enough under in vitro conditions to migrate across the DispoEq dialysis membrane over
the 24 hour period before degradation. Jones and Sabbioni took precautions to extract
remaining unreacted N-hydroxy arylamines after an overnight reaction.35 Therefore the
activated ABP was considered stable enough over the course ofthe 24 hour DispoEq
studies discussed below to remain reactive.
An earlier study using the caffeine / paraxanthine transition had 19 ppm as their
low point caffeine level and 155 ppm their high point level in their experiments. The
study performed here had 24 ppm caffeine available for reaction.96 Therefore the poor
quantitative results here may likely have been due to not using a high enough
concentration ofcaffeine. Also when the present caffeine metabolism studies were
performed the active G.S. was incubated in the H 2O bath for 3 minutes and then added to
the DispoEq tubes. This may have been another likely cause for the low paraxanthine
results. The protocol order ofadding G6PDH to the G.S. before pre-heating the G.S. may
have affected the outcome ofthis caffeine study. The most probable cause for poor
results was that the G.S. was actively producing NADPH for only 5 minutes instead of
the 20 as was the original design. With only 2 out ofthe 5 minutes ofNADPH
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production remaining with G.S. substrates present, the reaction time for paraxanthine
production was limited.
As mentioned in Chapter III there was some dispute ifit were P450 1A2 that
actually performed the N-oxidation,48 but P450 1A2 was one ofthe P450 enzymes in the
Sprague-Dawley rat liver S-9 fraction activating heterocyclic aromatic amines in a
similar reaction.97
The 24 hour permeability experiment to determine ifssDNA (13.9 kDa and 13.7
kDa for the sense and anti-sense strands respectively) would pass the 10 kDa MWCO
membrane was not successfully completed due to a malfunctioning UV
spectrophotometer. It was reasoned that if 194 Da caffeine passed the 10 kDa MWCO
membrane with only 57 % success, the 13+ kDa ssDNA would have less success passing.
As seen in Figure 29A and Figure 29B the folded ssDNA under the DispoEq conditions
was bulkier than simply random coil ssDNA. It was concluded not likely to pass the
membrane efficiently. It would theoretically be hindered from passage through the pores
ofthe membrane by such folding.
The removal ofNADPH by the S-9 as observed by a sudden increase and then
decrease in Abs340 over 15 minutes98 would have been a simpler experiment compared to
refining, calibrating and performing the caffeine / paraxanthine LC-UV method as
described in Chapter V. The NADPH monitoring method would have been non-specific,
pertaining to any enzyme that consumes NADPH and not exclusively P450 1A2.
The reason for the variability in retention times ofthe 303.3 ➔ 152 m/z MRM
detected adduct was thought to possibly be the result ofthree different variables:
incomplete hydrolysis ofthe ribosyl ofdeoxyadenosine, Watson-Crick base pairing ofthe
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hydrolyzed monomers with the Adn-8yl-ABP adduct and base stacking of the aromatic
biphenyl rings of ABP with nucleoside bases. The shorter retention time was surmised to
be due to incomplete hydrolysis of the ribosyl sugar from deoxyadenosine. Because of
its increased hydrophilic character the adducted nucleoside would elute earlier, retaining
with less hydrophobic interactions on the phenyl column. The ribosyl sugar would
possibly be unstable and undergo source fragmentation to the detected Adn-8yl-ABP.
The retention time configuration seen between 9.8 and 11 minutes was either due
to Watson-Crick base pairing with monomer bases (not likely, see next paragraph) or due
to base stacking interactions adduct with various hydrolyzed free bases in the solution.
The latter possibility for the protracted elution on the phenyl column was that aromatic
purine rings had pi-pi interactions with the biphenyl rings and had thus greater
interactions with aromatic LC column. Those aromatic interactions would also not be
strong enough to survive the 'source fragmentation' and the MRM transition of the
adduct would be detected. Guckian et al., when comparing changes in Tm of a 6-mer
duplex core with dangling ends composed of pyrimidines, purines and synthetic
nucleotides of aromatic compounds such as benzene, naphthalene, phenanthrene and
pyrene found that the greater the increase in aromatic character the greater the Tm.99 (The
definition of Tm is when half of the oligos are in duplex state and half are in random
coil).88
There did not appear to be any correlation between the varying hydrolysis
conditions and the length of agitation. In any case since the results under similar ssDNA
and ABP conditions were greater than with the S-9 present, the S-9 was not essential for
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the activation of ABP to react with ssDNA. The retention time observed for the final
ssDNA analyses was 9.8 minutes.
It was likely that because the oligonucleotide backbone was absent that the Adn
adduct did not pair with monomeric thymine pyrimidine base in the experiment for
Figure 26. The Tm for the monomer base pair of A-T was only 2° C when calculated 100
under the same conditions as used to calculate the folded structures.95 The Tm for the
sense strand was 53.6° C (see Figure 29A). The affinity of the Adn-adduct for the sense
strand in oligo form may have been greater than that of the thymine monomer
individually but the HCI hydrolyzed the oligo to free bases, and possibly nucleosides
ruling out this line of reasoning for the protracted retention times.
The mobile phase composition for the 9.8 minute retention time eluting peak (see
Table 7) was 100 % methanol. The mobile phase was 100 % methanol from 7 to 10
minutes. The last analyte peak eluted at 11.0 minutes. The column was just beginning
reequilibration when the last peak eluted.

Specificity of MRM Transition and Validity of Quantitation
Table 11 lists the possible known DNA-ABP adducts cited in the literature and
indicates that 303.3 ➔ 152 m/z transition was specific to Adn-8yl-ABP. As was
mentioned in Chapter VI the N-(guanine-N2-yl)-4-aminobiphenyl had a MW close to that
of the intended adduct of quantitation, Adn-8yl-ABP. But the span of 0.6 amu (that is±
0.3 amu) would not allow the passage of the 304.1 [M+Ht parent ion of N-(guanine-N2yl)-ABP. Any of the other possible ABP adducts were excluded even more so from
passage into the second collision quadrupole and towards detection in the third
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quadrupole as a 152 m/z daughter ion fragment. The MRM transition of 303.3 ➔ 152
m/z chosen for these analyses was specific to the desired Adn-8yl-ABP adduct.
For the chromatograms in Figure 27, SIN= 2. It is generally accepted that for the
lower limit of detection (LLOD) the SIN ratio should be 3 or greater. 101 When looking in
Table 10 the 90 % confidence intervals for the results were roughly 50% of the reported
values. These two factors did not bode well for the accuracy and precision of the results
respectively in terms of quantitation. The tabulated t for the 90 % confidence level for n
= 4 was 2.353 and the calculated t was 3.133 for comparing the results of the two tests.
Because the calculated t was greater than the tabulated value, there was a significant
difference between the results at this confidence level. In order to come to a result with
greater certainty more chromatograms would have been necessary to increase the degrees
of freedom allowing a higher confidence level tabulated t. (For a 95 % confidence level
4 do/tabulated is 2.776 and less than 3.133) There was a significant difference at the 90 %
confidence level at the experimental 3 do/with a tabulated of 2.353. When the results were
corrected for the loss of MS sensitivity their difference was no longer significant due to
increased relative error. The corrected results were not valid for comparison.

Laboratory and Computational Results Comparison
From the computational determinations there were 8 dA and 9 dG, or a total of 17
purines non-Watson-Crick paired and available for reaction on the sense strand. The
anti-sense strand had 5 dA and 4 dG, or 9 purines available for reaction. The competition
for the same amount of 10 ppm ABP available was greater among the purines on the

76
Table 11. Literature Cited DNA-ABP Adducts
Source: The predicted masses were calculated using the ACD/Labs Web service• and
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sense strand compared to those on the anti-sense strand. Furthermore since the adduct
forming with dA was quantitated and the ratio of available reactive dA to dG was less for
the sense strand than for the anti-sense strand. It followed therefore that there was less
Adn-8yl-ABP adduct quantitated on the sense strand than on the anti-sense strand. See
Figure 3 l for a bar graph representation comparison.

D Available dA
■ Available dG

Sense Strand

Anti-Sense
Strand

■ mol dA-ABP/E06 mol
Nucleotides

Figure 31. Reactant/ Product Comparison of DispoEq Coupling Reaction

Implications of Results for Bladder Cancer
The dGuo-8yl-ABP adducts in dsDNA were known to be repaired more
effectively than those of their ssDNA counterparts and the other minor adducts of ABP
were found to be more mutagenic.15 The implication was that dAdo-8yl-ABP adducts
were more mutagenic. The same mutagenicity of dAdo-8yl-ABP adducts had been
suggested by Hatcher et al. 51 Hainaut et al. cited speculations in their review that
adenine was affected by tobacco carcinogens.13 Shapiro et al. found the dAdo-8yl-ABP
adduct to lie more favorably in the minor groove thermodynamically than the dGuo-8yl-
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ABP adducts for whom the sequence was more of a determining factor of minor/ major
groove preference. 16 In Figure 32 the upper arrow points to the minor groove and the
lower arrow to the major groove (the original propamidine drug in the minor groove is
not shown here). B[a]P formed an adduct with guanine in the minor groove which
disturbed the B. stearothermophilus DNA polymerase's minor groove contacts and
blocked primer extension in replication.103
The mutational spectrum of dGuo-8yl-ABP adducts in embryonic fibroblasts of
the Big Blue mouse was not found to be in agreement with the patterns of TP53
mutations in human bladder cancer. The former was predominantly G ➔ T transversions

Figure 32. Major and Minor Grooves of dsDNA
Source: PDB ID: I 02D
Nunn et al., Sequence-dependent drug binding to the minor groove of DNA:
crystal structure of the DNA dodecamer d(CGCAAA TTTGCG)2
complexed with propamidine, J. Med Chem. 1995 (38) pp. 23 I 7-2325
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while the latter was G ➔ A transitions.5 But the authors cited predominance of G ➔ T
mutational spectrum of BPDE adducts matched the literature for the TP53 gene in lung
cancer.
For studying the fluorinated 7-fluoro-2-aminoflourene (FAF) analogue of the
DNA adduct N-(deoxyguanosine-8-yl)-2-aminofluorene (dG-C8-AF), NOESY 2dimensional 19F-NMR was used to determine if the dG-C8-FAF was affected by its
neighbor in a 12-mer duplex. It was found that when purine bases flanked the adduct on
the 3' side, the stacking (S-conformer) of FAF was preferred. The alternative position for
the base was to bind (B-conformer) to the Watson-Crick complementary base pair with
its FAF adduct in the major groove. 104 The greater the Van der Waals forces of stacking
the greater the S-conformer. Moreover, the higher the % S-conformer, i.e. the %
stacking, the higher the nucleotide excision repair. Cho et al. described that in NOESY
1H-NMR studies the major conformer of the dGuo-8yl-ABP adduct lies in the major
groove but there were minor conformers. The minor conformers were with ABP stacking
and as an adduct in the minor groove. The minor conformers were to have more
significance because they occurred at physiological temperatures.91 Blas-Machado et al.
did not observe any induced upregulation of p53 in the livers of Fundulus grandis fish
subjected to 2-AF in their feed. 105
The computationally derived configuration of the Arg 248 codon and overlapping
GNA triloop is depicted in Figure 25. The two guanine bases of the CGG codon stacked
anti-parallel to the adenine base 3' to them. If dA were to have the ABP substituent in
the C-8 position, the bound ABP would theoretically be able to stack with the two
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neighboring guanine for stabilization. Stabilization by Van der Waals forces between the
adduct and the DNA backbone could occur in instances of stacking. 103
There was a documented strand bias of 60 % for G-C ➔ A-T transitions at CpG
sites on the human bladder TP53 sense strand vs. 40 % on the anti-sense strand.13
Codons 245 and 248 were CpG sites and had mutations with this transition. An
unexplained bias for the anti-sense strand in BPDE binding affinity was observed in the
literature, but it was also noted that repair of BPDE adducts was 2 to 4 times slower on
the sense strand.106 Strand bias was later found to be associated with the G-C ➔ A-T
transition, transcription-couple repair preferentially repairing the bulky adducts of ABP
and BPDE on the anti-sense, that is the transcribed strand. 107 Pfeifer et al. stated that the
TP53 mutational pattern was determined by both initial DNA adduct levels and strand
bias in repair. 108
During replication in vivo bulky adducts at the replication fork caused
polymerases to pause and stall.109 Stalled replication forks were thought to result in
significant ssDNA. But no ssDNA was observed in EM. 110 As was said in Chapter I,
ABP is 50 times as mutagenic in ssDNA compared to dsDNA 15 Compared to the free
nucleoside, dsDNA is 2 % as reactive and ssDNA is 30 % as reactive to the nitrenium ion
intermediate.46 Greenblatt et al. described how TP53 gene frameshift mutations could be
explained by quasi-palindromes of one strand being folded back on itself for excision or
replication, using the other strand as a template.111 Greenblatt et al. implied that
secondary structure of ssDNA had a bearing on the mutational profile of adducts.
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CHAPTER VIII
CONCLUSIONS
The in vitro relative adduct level of dAdo-8yl-ABP adducts was determined to be
on the order of 5 to 15 adducts/ 106 nucleotides. This value compares to the literature
value35 for dGuo-8yl-ABP formed on DNA modified in vitro of 450.0 adducts/ 106
nucleotides. Furthermore the sense strand had fewer dAdo-8yl-ABP adducts compared to
the anti-sense strand with 5 ± 2 vs. 9 ± 4 per 106 nucleotides respectively (p = 0.10). By
computational determination the sense strand had 17 non-hydrogen bonding purines
available for reaction while the anti-sense strand had 9. The dA to dG ratio available for
reaction was 8 to 9 and 5 to 4 for the sense strand and the anti-sense strand, respectively.
The values of these three ratios in the VisualOMP6.0 determinations corroborated the
results found by LC-MS/MS of fewer adducts on the sense (coding) strand when the
complementary 45-mer oligos of TP53 exon7 were compared. The strand bias observed
was explained by simple, common mass balance relationships elucidated by the
computational calculations in contrast to the literature reported in vivo transcription
coupled repair on the anti-sense (transcription) strand of guanine adducts 107 These results
may also infer that ssDNA secondary structure and purine base ratios have an influence
on the "binding specificity" and "human genomic content" variables mentioned by Feng

et al. 11
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CHAPTERIX
FUTURE RESEARCH
An LC-MS method to determine the composition of the late eluting peaks is
necessary. The present LC-MS/MS method was tuned specifically to the 303.3 ➔ 152

mlz transition. The LC-MS method would be less sensitive, but scan for ions other than
303.3 m/z and determine the accompanying analyte composition at those retention times.
Table 12 gives a suggested experimental setup. In order to accommodate the decrease in
sensitivity the sense strand DNA concentration used would be the greatest available or
5975 pmol on the LC column.
Table 12. Experimental Paradigm toInvestigate Late Eluting LC-MS/MS Peaks
H dro sis of 5975 mo! TP53 exon7 sense strand 2 hr., 75° C
Test 1
ssDNA in 2xKPhos
10 mABP
75
LONHCI

75

H drol sis of 10
Test 3
mAdo
10 mABP
l.ONHCI

mAdenosine 2 hr., 75° C)
Test 4
75

Adn-8 1-ABP

A possible area of research extending from the computational findings would be
to investigate the characteristics of the GNA triloop associated with the Arg 248 hotspot

83
codon on the sense strand as depicted in Figure 25. A NOESY 1H-NMR structural
characterization could be made such as performed by Cho et al. 91 Only bases C39
through 045 at the 3' end of TP53 exon7 sense strand would be necessary for the
determinations and would reduce the analysis to the triloop area. The objective would to
be to observe the stacking of the three purine bases in the triloop to verify the RNA-123
computational rendition of the structure. From there the potential stability of an ABP
moiety of a dAdo-8yl-ABP stacking with the neighboring guanines in the loop and
further stabilizing the configuration could be projected.
Another study would be to characterize the stacking of the adducted dAdo in the
ONA Triloop. Guckian et al. cite that naphthalene - adenine stacking was stronger than
adenine - adenine stacking.99 To achieve this NOESY 19 F-NMR could be used with a
terminally mono-fluorinated ABP.104 Unfortunately all of the three literature references
obtained for possibly incorporating an adducted base into an oligo coupled the adduct to
the guanine after the purine was already in place. Steps were taken to allow only one
guanine, the one of interest to be available for reaction.104• 112• 113 When multiple
guanines were available, multiple adduct products were also encountered.104• 113
A second set of experiments would be to determine products obtained through the
activity of the PCR polymerase on TP53 exon7 sense strand at progressively increasing
temperatures approaching the annealing temperature of the fully random coil template
oligo. The sequence would be analyzed at the complementary ends of the synthesized
product that had paired with the original 3' end of the template exon7. Of interest would
be how strongly the triloop blocks the action of the polymerase as it progresses up the
exon7 template. For that matter the bulge at Gly245 would also hinder the action of the
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polymerase (see Figure 33). If an dAdo-8yl-ABP adduct could be positioned in some
way at the A43 position of a duplex of exon 7 's sense strand a study could be performed
to determine if the adduct lay in the minor groove. The effect of blocking the polymerase
during PCR in the full temperature range of the cycle could be determined. 16• 103
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Figure 33. GNA Triloop and Bulge-Looped TP53 exon7 Sense Strand
Codon 248 Circled at the 3' End -dG and dA Available for Attack from
Activated ABP
Codon 245 Circled in Middle -Two dG Available for Attack from Activated
ABP
Source: Structure Determined Computationally with Visua!OMP6.0, DNA Software,
Inc., Ann Arbor, MI
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ABBREVIATIONS
ABP, 4-aminobiphenyl; Adn and A, adenine; Ado, adenosine; dA and dAdo,
deoxyadenosine; Gua and G, guanine; Guo, guanosine; dG and dGuo, deoxyguanosine;
C, cytosine; 5mC, 5-methyl cytosine; T, thymine
N-OH-ABP, N-hydroxyl-4-aminobiphenyl; N-OH-AABP, N-OH-4-

acetylaminobiphenyl; dA-C8-4-ABP and dAdo-8yl-ABP, N-(deoxyadenosin-8-yl)-4aminobiphenyl; Adn-8yl-ABP, N-(adenine-8yl)-4-aminobiphenyl; dG-C8-4-ABP and
dGuo-8yl-ABP, N-(deoxyguanosin-8-yl)-4-aminobiphenyl; dG-N2-4-ABP and dGuo-N2ABP, N-(deoxyguanosin-N2-yl)-4-aminobiphenyl; dG-N2-4-AABP, 3-(deoxyguanosin
N2 -yl)-4-acetylaminobiphenyl; FAF, 7-fluoro-2-aminoflourene; dG-C8-AF, N(deoxyguanosine-8-yl)-2-aminofluorene
Ar, biphenyl; UDPGA, UDP-glucuronic acid; UGT, UDP-glucuronide
transferase; Gluc, glucuronide; PHS, prostaglandin H-synthase; NO, nitric oxide; B[a]P,
benz[a]pyrene; BPDE, benz[a]pyrene diol epoxide; NAT, N-acetyltransferase
ssDNA, single stranded DNA; dsDNA, double stranded DNA; ct-DNA, calf
thymus DNA; PCR, polymerase chain reaction; Tm, melting temperature (for DNA); S
conformer, stacking conformer; B-conformer, binding conformer
ES, electrospray; ESI, electrospray ionization; LC-MS, liquid chromatography
mass spectrometry; LC-MS/MS, liquid chromatography tandem mass spectrometry; ES
MS, infusion electrospray mass spectrometry; NOESY, Nuclear Overhauser Effect
Spectroscopy; KIE, kinetic isotope effect
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MRM, multiple reaction monitoring; RIC, relative ion count, AU, absorbance
units; V, volts; Da, Dalton; m/z, mass/charge; amu, atomic mass unit; i.d., inner diameter;
SIN, LC signal to noise ratio; LLOD, lower limit of detection; LM/HM, low molecular

weight I high molecular weight; SPE, solid phase extraction; G.S., generating system;
™

DispoEq, DispoEquilibrium DIALYZERS ; RBC, red blood cell
!ARC, International Agency for Research on Cancer; PDB, Protein Data Bank;
MSU-MSF, the Michigan State University-Macromolecular Structure Facility
P450, pigment at 450 nm; CYP, cytochrome P450; p53, protein at '53 kDa'; G6P,
glucose-6-phosphate; G6PDH, glucose-6-phosphate dehydrogenase; PEG, polyethylene
glycol; (see also chemicals subchapter for abbreviations)
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Source:
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